Research Publications

Chapters Published in Books
1. Singh S, Singh N. Seroepidemiology of Toxoplasmosis in sheep and goats of Rajasthan and their butchers.IN: Somvanshi R, Lokeshwar RR (Eds.). Current Advances in Veterinary Science and Animal Production in India. Lucknow, International Book Publishing Co. 1994: PP 204-12.
2. Singh S, Chang KP. Genetic Heterogeneity of Indian Leishmania Donovani. IN: Kala-azar Research in India. Sundar S (ed.), IMS, Banaras Hindu University, Varanasi, 1996: pp 197-204.
3. Singh S, Recent Advances in the Laboratory diagnosis of Leishmaniasis. IN: Kala-azar Research in India. Sundar S, Sundar S (ed.), IMS, Banaras Hindu University, Varanasi, 1996: pp 39-56.
4. Singh S, Toxoplasma gondii in animal health. IN: Prospects of Livestock and poultry Development in 21st Century. Verma R &Johari DC (Eds.), IVRI, Bareilly, 1997: pp 204-212.
5. Singh S, Clinical Significance of Physiologic parameters. Biswas NR, Jain DK, Jain SK. (Eds.), Hospital and Clinical Pharmacy, RP Centre for Ophthalmic Sciences, New Delhi, 1997 pp 86-95.
6. Singh S, Opportunistic infections in Immunosuppressed Humans and Animals. In: An Introduction to Immuno-pathology, Chauhan RS (Ed), GB Pant University of Agriculture & Technology, Pantnagar, 1998 pp 239-272.
7. Singh S, Toxoplasma: An emerging disease in man and animals. Zoonotic Parasites- their diagnosis and control” A h andbook of III National Training Programme, Centre forAdvanced Studies. Department of Parasitology, Veterinary College, University of Agricultural Sciences, Bangalore, 1998 pp 97-100.
8. Singh S, Cytomegalovirus infection and its diagnosis in organ transplant recipients. Viral infections in Nephrology. Aggarwal S (ed), New Delhi, 1999.
9. Singh S, Dubey JP. Human Toxoplasmosis in India before and after AIDS epidemic. Toxoplasmosis in India. Singh S (Editor). Second Edition, Pragati Publishing Company, Ghaziabad & New Delhi, 1999.
10. Somvanshi R, Singh S. Spontaneous Toxoplasmosis in Laboratory Rats. Toxoplasmosis in India. Singh S (Editor). Second Edition, Pragati Publishing Company, Ghaziabad & New Delhi, 1999.
11. Singh S. Advances in cellular and molecular biology of Toxoplasma gondii. Toxoplasmosis in India. Singh S (Editor). Second Edition, Pragati Publishing Company, Ghaziabad & New Delhi, 1999.
12. Singh S. Cytokines in Toxoplasmosis.Toxoplasmosis in India. Singh S (Editor). Second Edition, Pragati Publishing Company, Ghaziabad & New Delhi, 1999.
13. Biswas NR, Singh S. Treatment of acquired Toxoplasmosis. Toxoplasmosis in India. Singh S (Editor.). Second Edition, Pragati Publishing Company, Ghaziabad & New Delhi, 1999.
14. Singh S, Singh N. Conjugal Toxoplasmosis. Toxoplasmosis in India. Singh S (Editor.). Second Edition, Pragati Publishing Company, Ghaziabad & New Delhi, 1999.
15. Singh S. Common questions asked by a pregnant woman about toxoplasmosis. Toxoplasmosis in India. Singh S (Editor.). Second Edition, Pragati Publishing Company, Ghaziabad & New Delhi, 1999.
16. Singh S. Diagnostic and Prognostic markers of anti-kala-azar therapy and vaccination. IN: Proceeding of V Round Table Conference Series. No. 5. Gupta S & Sood OP (Ed). Ranbaxy Science Foundation, New Delhi. 1999 pp 95-114.
17. Singh S. Diagnosing Human Immunodeficiency virus infection and AIDS. IN: Proceeding of VI Round Table Conference Series. No. 6. Gupta S &Sood OP (Ed). Ranbaxy Science Foundation, New Delhi. 2000 pp 51-90.
18. Singh S. Anti-Leishmania therapy. IN: Antimicrobials in Laboratory Medicine. Rattan A. (Ed). B.I. Churchill Livingstone Pvt. Ltd. New Delhi, 2000: pp 221-234.
19. Singh S... Strongyloidiasis in Man and Animals. IN: Text Book of Helminthology in India. Sood ML. (ed). Ludhiana. International Book Distributors, Dehradun, 2001: pp 167-186.
20. Singh S.. Immunology and Immunological Diagnosis of Toxoplasmosis. IN: Advances in Immunology and Immunopathology. Chauhan RS, Singh GK, Agarwal DK (eds). Society for Immunology and Immunopathology, Pant Nagar, 2001: pp190-201.
21. Singh S., Jose K.J., Biswas A. Blood borne viruses transmission (Hepatitis, HIV) via unsterile needles and prevention. In : AIDS INDIA. Report of the, third international conference on AIDS India. Chapter VIII..Samuel N.M. & Upham Nance (eds), The Department of Experimental Medicine & AIDS Resource Centre, The Tamil Nadu Dr. M.G.R. Medical University, Chennai, India. 2002 pp 25-29.
22. Singh S.. AIDS associated intestinal parasitic infections: diagnostic aspects. IN: Diarrhoeal diseases: current status, Research trends and field studies. Raghunath D, Nayak R. (eds). Tata McGraw-Hill Publishing Co. Ltd., New Delhi, 2003 pp:36-56.
23. Singh S. & Sivakumar R. Laboratory Diagnosis of Visceral Leishmaniasis. In: Trend and Research in Leishmaniasis. Raghunath D, Nayak R. (eds). Tata McGraw-Hill Publishing Co. Ltd., New Delhi, 2005 pp: 113-130.
24. Singh S.. Laboratory Diagnosis of HIV. Manual for management of HIV/AIDS in Children. NACO/IAP/UNICEF. New Delhi. 2005 p 171.
25. Singh S., Sood R. Rattan A. Mycobacterium tuberculosis. IN, Essential of Tuberculosis in Children. Seth V & S K Kabra (editors). J P Brothers Medical Publishers Pvt. Ltd., New Delhi. 2006, pp 51-65.
26. Singh S.. & Gupta S. Laboratory Investigations in Emergency. Manual of Medical Emergencies, Pushpanjali Medical Publications Pvt Ltd, Delhi; 3rd Edition, 2007 pp 846 – 860.
27. Singh S.. Avidity Testing to Pinpoint Timing of maternal Infections during Pregnancy. Congenital Intrauterine Infections. Deepika Deka (editor). J P Brothers Medical Publishers Pvt. Ltd., New Delhi. 2009, pp 81-89.
28. Singh S.. Laboratory techniques for Prenatal Diagnosis of Maternal-Fetal Infections. Congenital Intrauterine Infections. Deepika Deka (editor). J P Brothers Medical Publishers Pvt. Ltd., New Delhi. 2009, pp 195-211.
29. Singh S.. Human Toxoplasmosis a food borne parasitic disease. In: Toxoplasmosis in India. Singh S. (Editor.). Third Edition, Pragati Publishing Company, Ghaziabad & New Delhi, 2010.
30. Singh S.. Cellular and Molecular Biology of Toxoplasma gondii. In: Toxoplasmosis in India. Singh S. (Editor.). Third Edition, Pragati Publishing Company, Ghaziabad & New Delhi, 2010.
31. Singh S.. Cytokines in Toxoplasmosis. In: Toxoplasmosis in India. Singh S. (Editor.). Third Edition, Pragati Publishing Company, Ghaziabad & New Delhi, 2010.
32. Singh S.. Toxoplasmosis in AIDS Patients. In: Toxoplasmosis in India. Singh S. (Editor.). Third Edition, Pragati Publishing Company, Ghaziabad & New Delhi, 2010.
33. Singh S.. Laboratory Diagnosis of Toxoplasmosis. In: Toxoplasmosis in India. Singh S. (Editor.). Third Edition, Pragati Publishing Company, Ghaziabad & New Delhi, 2010.
34. Singh S.. Avidity Testing to Pinpoint Timing of Maternal Torch Infection during Pregnancy. In: Toxoplasmosis in India. Singh S. (Editor.). Third Edition, Pragati Publishing Company, Ghaziabad & New Delhi, 2010.
35. Singh S.. Incidence and Prevalence of Toxoplasmosis in Pregnant Women. In: Toxoplasmosis in India. Singh S. (Editor.). Third Edition, Pragati Publishing Company, Ghaziabad & New Delhi, 2010.
36. Singh S.. Treatment of acquired Toxoplasmosis. In: Toxoplasmosis in India. Singh S. (Editor.). Third Edition, Pragati Publishing Company, Ghaziabad & New Delhi, 2010.
37. Singh S.. Common questions asked by a pregnant woman. In: Toxoplasmosis in India. Singh S. (Editor.). Third Edition, Pragati Publishing Company, Ghaziabad & New Delhi, 2010.
38. Singh S., Gopinath K, Sood R. Rattan A.Mycobacterium tuberculosis. IN, Essential of Tuberculosis in Children. Vimlesh Seth & S K Kabra (editors). J P Brothers Medical Publishers Pvt. Ltd., New Delhi. 2011, pp 41-56.
39. Singh S., Gopinath K, Rattan A. Non-Tuberculous Mycobacteria. IN, Essential of Tuberculosis in Children. Vimlesh Seth & S K Kabra (editors). J P Brothers Medical Publishers Pvt. Ltd., New Delhi. 2011, pp 57-65.
40. Munawwar A, Singh S.. Hepatitis B and C viral Co-infections in AIDS Patients. Proceedings of International Conference on Biotechnological approaches to neuroimmunomodulation and infectious diseases. Singh PP (editor): 2008: pp 175-188.
41. Tarai B, Bawa N, Singh S., Rattan A. Laboratory Diagnosis of Mycobacterial (Tuberculosis) Infections in Children: Conventional Methods. IN, Essential of Tuberculosis in Children. Vimlesh Seth & S K Kabra (editors). J P Brothers Medical Publishers Pvt. Ltd., New Delhi. 2011, pp 322-331.
42. Mishra J, Saxena A,Singh S. Chemotherapy of Leishmaniasis: Past, Present and Future. IN: Frontier in Medicinal Chemistry. Allen B. Reitz / Atta-ur-Rahman / M. Iqbal Choudhary (Eds.), Bentham Science Publishers. 2012, Vol 6 pp 97-130.
43. Sankar P, Mishra J, Srivastava S, Singh S.. In-vitro diagnostic methods for visceral leishmaniasis. IN: Advances in developing affordable in vitro molecular diagnostics. Puri CP, Abidi N, Bhanushali P, Pere A, Gupta SK (eds.) Yashraj Research Foundation, Navi Mumbai, 2013: pp 111-138.ISBN No: 978-81-910540-40.
44. Sankar P, Mishra J, Singh S.. Hepatitis A and E in Potable Water: A threat to Health. IN: Water & Health. Singh PP & Sharma VP (Eds). Springer India. 2014, pp 29-51.
45. Srivastava S, Shankar MM, Singh S.. (2016) Molecular diagnosis of tuberculosis, leishmaniasis and toxoplasmosis: The three intracellular pathogens. Dutta A. (ed.) The National Academy of Sciences, India (NASI). ISBN No. 978-93-81891-31-5 pp. 127-157.
46. Gupta A, Singh A, Singh S. Glycogen as Key Energy Storehouse and Possibly Responsible for Multidrug Resistance in Mycobacterium tuberculosis. IN: Drug Resistance in Bacteria, Fungi, Malaria and Cancer. Arora G, Sajid A, Kalia VC (Editors), Nature Springer, Switzerl and, 2017, pp 263-85.ISBN:978-3-319-48682-6.
47. Srivastava S, and Singh S. Toxoplasmosis: a zoonotic disease of extreme importance in pregnant women and immunocompromised patients. Yadav AK, T andon V, Hoti SL (Eds). Advances in medico-veterinary parasitology: an Indian perspective. Panima Publishing Coorp. New Delhi; 2018, pp 93-106. ISBN:81-8653-589-2.
48. Rufai SB, Gupta A, Singh S. Prion Diseases: A Concern for Mankind. in Pathogenicity and Drug Resistance of Human Pathogens 2019 (pp. 283-302). Springer, Singapore. https://doi.org/10.1007/978-981-32-9449-3_14.
49. Gupta AK, Singh A, Singh S. Diagnosis of Tuberculosis: Nano diagnostics Approaches. In: Nano-Bio-Medicine 2020 (pp. 261-283). Springer, Singapore.DOI: 10.1007/978-981-32-9898-9_11 PMCID: PMC7122355.
50. Singh A, Gupta AK, Singh S. Molecular Mechanisms of Drug Resistance in Mycobacterium tuberculosis: Role of Nanoparticles against Multi-drug-Resistant Tuberculosis (MDR-TB). In: Nano-Bio-Medicine 2020 (pp. 285-314). Springer, Singapore. https://doi.org/10.1007/978-981-32-9898-9_12.

RESEARCH PAPERS PUBLISHED
1. Kochhar R, Talwar P, Singh S, Mehta SK. Invasive c andidiasis following cimetidine therapy. Am J Gastroenterol 1988; 83: 102-3. (IF: 5.608)
2. Kochhar R, Singh S, Talwar P, Mehta SK. C andidiasis after cimetidine therapy. Gastrointest Endoscopy 1988; 34: 283-4. (IF: 4.825)
3. Singh S*,Samantaray JC. Human Intestinal myiasis. J Assoc. Phys India 1988; 39(12): 741-2.
4. Singh S*,Samantaray JC. Blood films in the diagnosis of Malaria. Lancet 1989; II: 1165-66. (IF: 25.8)
5. Singh S*, Kochhar R, Singh N, Talwar P, Mehta SK. Endoscope contaminated with Trichosporonbeigelli. J Hosp Infection 1989; 14: 49-53. (IF: 2.442)
6. Singh S*, Samantaray JC. Tropical anthelminthic treatment of recurrent genitourinary enterobiasis. Genitourinary Medicine 1989; 65: 284-6. (IF: 3.427)
7. Singh S*, Singh N, Samantaray JC, T andon BN. Filarial ascites associated with carcinoma of pancreas. Am J Gastroenterol 1989; 84: 1131. (IF: 5.608)
8. Singh S*, Kochhar R, Datta U. Severe duodenal C andidiasis in an IgA deficient patient with associated T cell defects. Indian J Gastroenterol 1990; 9: 95-6.
9. Singh S*, Singh N, Samantaray JC, Roy S, Garg SP. Scalp phthiriasis. Rev Infect Dis 1990; 12: 560.
10. Singh S*,Samantaray JC, Bhargava DK. Giant hydatid cyst of gastrosplenic ligament simulating massive ascites. J Clin Gastroenterol 1990; 12: 481-2. (IF: 2.403)
11. Singh S*,Samantaray JC. So called non-pathogenic intestinal parasites. Am J Gastroenterol 1990; 85:764-5. (IF: 5.608)
12. Singh S*,Samantaray JC, Kinra G. Genito-urinary Enterobius vermicularis infection: vagina acting as reservoir. Indian J Med Microbiol 1989; 7: 152-4.
13. Singh S*,Samantaray JC, Sharma MP. Fatal strongyloidiasis in India. Indian J Gastroenterol 1990; 9: 100.
14. Wali JP, Aggarwal P, Gupta U, Saluja S, Singh S. Ketoconazole in treatment of visceral Leishmaniasis. Lancet 1990; 336: 810-811. (IF: 25.8)
15. Singh S*, Rattan A, Samantaray JC. Spirochetal dysentery. A case report with review of literature. Tropical Gastroenterol 1990; 11(3): 152-7.
16. Singh S. Laboratory diagnosis of intestinal parasitosis. Indian J Paediatr 1990; 57: 789-92.
17. Singh S* Rattan A, Samantaray JC. Acute spirochetal dysentery in a child with Fallot’s tetralogy. Am J Gastroenterol 1991; 86: 655-6. (IF: 5.608)
18. Singh S* Singh N, Kochhar R, Jatava LK, Talwar P, Mehta SK. C andidaalbicans and human ABO Blood groups. Indian J Med Microbiol 1991; 9(1): 34-39.
19. Singh S*. Trematodes in Indian: A review. Trop Gastroenterol 1991; 12:119-131.
20. Singh S*,Nautiyal BL. Seroprevalence of Toxoplasmosis in Kumaon region of India. Indian J Med Res 1991; 93: 247-49. (IF: 1.224)
21. Singh S*, Urine analysis in paediatric practice. Indian J Paediatr 1991;58: 717-23.
22. Singh S*, Fungal Diarrhoea. Mycopathologia 1991; 114: 41-42. (IF: 0.915)
23. Fotedar R, Banergee U, Singh S*Shriniwas, Verma AK. House fly (Musca domestica) as a carrier of pathogens in a hospital environment. J Hosp Infect 1992; 20(3): 209-215. (IF: 2.442).
24. Singh S* Singh N, Kochhar R, Talwar P, Mehta SK. Cimetidine therapy and duodenal c andidiasis: Role in healing process. Indian J Gastroenterol 1992; 11: 21-2.
25. Singh S*Spiramycine in the treatment of toxoplasmosis is it worth in developing countries like India. J Assoc Physician India 1992; 40: 140.
26. Singh S* Das SC. Paramecium colonising urinary tract of a patient on dialysis: a rare entity. Nephron 1992; 62: 243-44. (IF: 1.574)
27. Singh S* Rattan A, Kumar S. Skin tuberculosis due to Mycobacterium chelonei after a yellow jacket bite. Tuber Lung Dis 1992; 73(5): 305-6. (IF: 2.035)
28. Singh S*, Gupta S, Singh YN, Mirdha B, Hak B. Large single c andidal liver abscess treated with aspiration and antifungal drugs. Indian J Gastroenterol 1992; 11: 176-77.
29. Singh S*, Singh N, Roy S, Garg SP. Family outbreak of scalp phthiriasis. Indian J Paediatr 1992; 59: 639-42.
30. Singh S*, Singh YN. Gastrointestinal tuberculosis in a SLE patient: diagnosis by stool examination. J Assoc. Physician India 1992; 40: 135-6.
31. Wali JP, Aggarwal P, Gupta U, Saluja S, Singh S. Ketoconazole in the treatment of stibomine and pentamidine resistant kala-azar. J Infect Dis 1992; 166: 215-6. (IF: 5.363)
32. Singh S*,Saluja S, Mirdha B. Resistant Malaria simulating Indian Kala-Azar. Indian Practitioner 1992; 45: 815-9.
33. Singh S*.Pseudoresistant malaria in tropical countries. Lancet 1992; 340: 1419-20. (IF: 25.8)
34. Singh S*, Sharma MP. Strongyloidesstercoralis in Northern India. Indian J Med Microbiol 1992; 10:197-203.
35. Mirdha B, Singh S*. Transient Isosporiasis in an apparently normal child. Indian J Paediatric 1993; 60: 197-99.
36. Singh YN, Singh S*, Rattan A, Samantaray JC, Wali JP, Malaviya AN. Pneumocystis carinii infection in AIDS patients: First report from India. J Assoc Physic India 1993; 41: 41-42.
37. Rattan A, Gupta SK, Singh S et al. Detection of antigens of Mycobacterium tuberculosis in patients of infertility by monoclonalantibody based s andwich ELISA. Tuber Lung Dis 1993; 74: 200-03. (IF: 2.2)
38. Singh S*, Singh N, Karmarkar MG. Low cost Refractometer for measurement of protein concentration and specific gravity of body fluids. Tropical Doctor 1993; 23: 171-3. (IF: 2.291)
39. Singh S*, Singh N, Samantaray JC, Das GB, Verma IC. Trichuris vulpis infection in an Indian tribal population. J Parasitol 1993; 79: 457-8. (IF: 1.3)
40. Singh S*, Raju GV, Samantaray JC. Parasitic gut flora in a North Indian population with Gastrointestinal symptoms. Trop Gastroenterol 1993; 14(3): 104-108.
41. Singh S*, Singh N, P andav R, P andav CS, Karmarkar MG. Toxoplasma gondii infection & its association with Iodine deficiency in a residential school in a tribal area of Maharashtra. Indian J Med Res 1994; 99: 27-31. (IF: 1.624)
42. Singh S*. Risk factors for salmonella infection: loss of gastric acidity linked to c andidiasis. High risk in developing countries. BMJ 1994; 308:596-7. (IF: 9.224)
43. Rattan A, Kishore K, Singh S*, Jaber M, Xess I, Kumar R. Evaluation of a safe sputum processing method for detecting tuberculosis. J Clin Pathol 1994; 47: 411-13. (IF: 2.245)
44. Sharma M, Reed SL, Singh S*, Talwar GP, Ghosh S. Characterisation of monoclonal antibodies to conserved antigens of Entamoeba histolytica and E. dispar and development of stool ELISA. Hybridoma 1994; 13: 123-130. (IF: 0.411)
45. Singh S*, Sachdev MPS. Acanthamoeba keratitis. British Med J 1994; 309: 273. (IF: 9.224)
46. Singh S*. Sex education in Indian schools. Natl Med J India 1994; 7: 194-5. (IF: 1.0)
47. Singh S*,Ahlawat S, Singh N, Chaudhary VP. High seroprevalence of TORCH infections in multiply transfused b-thalassemic children in India. Eur J Haematol 1995; 54: 64-66. (IF: 1.863)
48. Suri M, Kabra M, Singh S*, Rattan A, Verma IC. Group B meningococcal meningitis in India. Sc and J Infect Dis 1995; 26: 771-3. (IF: 1.56)
49. Singh S*, Singh N, Razavi KA. Tuberculosis following immunosuppressive treatment after exposure to toxic smoke. Lancet 1995; 345: 1379-80. (IF: 25.8)
50. Ahlawat S, Singh S*, Bhargava M. Tumour necrosis factor-a, a marker of disease activity in acute lymphoblastic leukaemia: a preliminary report. Indian J Haematol Blood Transf 1995; 13: 61-63.
51. Singh S*, McGwire BS, Chang KP. Kinetoplast and nuclear DNA polymorphism of visceral Leishmania isolates from North-eastern India. J Protozool Res 1995; 5: 27-32.
52. Singh S*, Gilman-Sacks A, Chang KP, Reed SG. Diagnostic and prognostic value of rK39 antigen in Indian Leishmaniasis. J Parasitol 1995; 81: 1000-3. (IF: 1.3)
53. Singh S*, Singh N, H anda R. Tumour Necrosis Factor-a in malaria and its correlation with disease prognosis. J Parasit Dis 1995; 19: 127-30.
54. Singh S*. Recent advances in the laboratory diagnosis of intestinal parasitosis (editorial). Trop Gastroenterol 1996; 17: 1-5.
55. Singh S*, Chaudhary VP, Wali JP. Transfusion-transmitted Kala-azar in India. Transfusion 1996; 36: 848-9. (IF: 3.278)
56. Bhaskar S, Singh S*, Sharma M. A single-step immunochromatographic test for the detection of Entamoeba histolytica antigen in stool samples. J Immunol Methods 1996; 196: 193-98. (IF: 2.402)
57. H anda R, Wali JP, Kaushik P, Gupta R, Singh S*, Gambhir M, Wig N, Biswas A, Aggarwal P. Toxoplasma encephalitis in AIDS. J Assoc Physic India 1996; 44: 838.
58. Singh S*, Singh N, ManiarJK. AIDS associated Toxoplasmosis and its correlation with Tumour Necrosis Factor alpha. J Parasit Dis 1996; 20: 49-52.
59. H anda R, Singh S*, Singh N, Wali JP. Fever of unknown origin: a prospective study. Trop Doctor 1996;26: 169-70. (IF: 0.391)
60. Wali, J.P., Singh S*. Tuberculosis as an occupational hazard in health care workers. Israel J Occ Hazards, 1996. (suppl): 8-9.
61. Singh S*, Singh N. Re-using unsterile needles: HIV reaches in small villages of rural India. Integration 1996; I: 17.
62. Singh S*.Alkylphosphocholine in visceral Leishmaniasis: in-vitro and in-vivo study. J Parasit Dis 1996; 20:185-8.
63. Singh S*. Automated microbiology culture system for up gradation of the emergency Microbiology Services. J Acad Hosp Adm 1997; 8: 17-20.
64. Singh S*, Singh N, Dwivedi S.N. Evaluation of seven commercially available kits for the sero-diagnosis of Toxoplasmosis. Indian J Med Res 1997; 105: 103-7. (IF: 1.224)
65. Singh S*. Toxoplasmosis. Vaigyanik (Hindi); April-June 1997: 49-51
66. Singh S*. AIDS Care in India. AIDS Reader 1997; 7: 101-106.
67. Singh S*, Singh N, H anda R. High serum levels of TNF-a in malaria and Kala-azar. J Assoc Physic India 1997; 45: 526-29.
68. Wig N, H anda R, Aggarwal P, Biswas A, Singh S*,Wali JP. Kala-azar in AIDS. J Assoc Physic India. 1997; 45: 582.
69. Wali JP, Aggarwal P, N andy A, Singh S*, Addy M, Guha SK, Dwivedi SN, Karmarkar MG, Maji AK. Efficacy of Sodium Antimony gluconate and Ketoconazole in the treatment of Kala-azar: a comparative study. J Commun Dis 1997; 29: 73-83.
70. Singh S*. AIDS epidemic in India. Drug Bulletin. 1997; 6 (2): 1-16.
71. Singh S*. Toxoplasmosis in India: before and after AIDS epidemic. Ann National Acad Med 1997;33:15-24.
72. Singh S*,Somvanshi R. Manav aurlabhkaripashuon ka rogjanak: Toxoplasma. Vigyan Garima Sindhu 1997; 22: 95-102.
73. Singh S*,Lodha R, Passi GR, Bhan MK. Cholistatic jaundice due to congenital Toxoplasma gondii infection. Indian J Paediatr 1998; 65: 154-57. (IF: 0.92)
74. Singh S*, Prasad R, Mohanty A. HIV and Hepatitis-B viral infections in Jailmates of Ghaziabad, North India. Proceedings 12 World AIDS conference, (Geneva), 1998 Monduzzi Editors, Bologna: 159-162.
75. Dwivedi SN, Singh S. On the economy in blood testing: A clinical Appraisal. ISMS Bulletin 1998; 13: 19-21.
76. Biswas NR, Sen S, Singh S*, Gopal N, P andey RM, Giri D. Sub-acute toxicity study of a polyherbal drug (Prostina) in rats. Indian J Pharmacol 1998; 30: 239-244.
77. Somvanshi R, Singh S. A case report of Spontaneous Toxoplasmosis in Laboratory Rats. J Vet Parasitol 1998; 12: 141-2.
78. Singh S*, Singh C. Sentinel surveillance of Chlamydia trachomatis in school going girls and women with secondary infertility in Delhi. J Trop Paediatr 1998; 44: 377-8. (IF: 0.592)
79. Singh S*, Shalini, Astha, S Peter, Aggarwal P, Wali JP. Disseminated fatal Nocardia farcinica in Acquired Immunodeficiency Syndrome. J Assoc Physic India. 1998;46:1053-6.
80. H anda R, Singh S*, Singh N, Wali JP. Brucellosis in North India: results of a prospective study. J Commun Dis 1998, 30: 85-87.
81. Aggarwal P, H anda R, Singh S*,Wali JP. Kala-azar- New developments in diagnosis and treatment. Indian J Paediatr 1999; 66: 63-71. (IF: 0.92)
82. Singh S*,Guleria R, Kumar S. Multidrug Resistant Fatal Falciparum Malaria in a Pregnant Woman. J Assoc Physic India 1999; 47: 346.
83. Singh S*, Prasad R, Mohanty A. High prevalence of sexually transmitted and blood borne infections amongst the inmates of a District Jail in North India. Int J STD AIDS 1999; 10 (7):475-78. (IF: 1.274)
84. Singh S*,Biswas A, Wig N, Aggarwal P, Sood R, Wali JP. A new Focus of Kala-azar cases in Kumaon region of India. J Commun Dis 1999; 31 (2): 73-77.
85. Singh S*. Hookworm disease misdiagnosed as intestinal lymphoma: transfused 38 units of blood. Sc and J Infect Dis 1999; 31: 217. (IF: 1.56)
86. Singh S*, Singh N, Singh C. Seroprevalence of Chlamydia trachomatis antibodies in school going girls vis-à-vis women with BOH and secondary infertility. Indian J Med Microbiol 1999; 17: 142-5. (IF: 0.75)
87. H anda R, Wali JP, Singh S*,Aggarwal P. A prospective study of Lyme arthritis in North India. Indian J Med Res 1999; 110: 107-9. (IF: 1.224)
88. Singh S*, Sood R, Wali JP, Dwivedi SN. Hepatitis B, C and Human Immunodeficiency virus infection in multiply injected Kala-azar patients in Delhi. Sc and J Infect Dis 2000; 32(1): 3-6. (IF: 1.56)
89. Singh S*, Singh R, Dwivedi SN. Blood borne viral infections in kala-azar patients receiving injectable anti-leishmnaial drugs in Bihar. J Lab Med, 2000, 1: 9-16.
90. Singh S*,Veena Kumari, Guleria R, P ande JN. Fatal hepatitis E virus infection presenting as haemorrhagic pneumonia in an adult Indian patient. J Lab Med, 2000, 1: 17-18.
91. Singh S*, Kumar J, Singh R, Dwivedi SN. Hepatitis B and C viral infections in Kala-azar patients receiving injectable anti-kala-azar treatment. Intern J Infect Dis 2000; 4: 203-8. (IF: 2.52)
92. Singh S*. Biological Contamination of Drinking water in New Delhi: Isolation of Free living amoebas as a highly sensitive index of water contamination. Water International 2000; 25 (3): 403-9. (IF: 0.5)
93. Tyagi M, Singh S*, Singh H. Iodinated natural rubber latex: preparation, characterisation & antibacterial activity assessment. Artif Cells Blood SubstitImmobilBiotechnol 2000;28(6):521-33.
94. Tyagi M, Singh S*, Rattan A, Singh H. Surface modification and antimicrobial evaluation of foley’s urinary catheter. Trends in Biomaterials & Artificial Organs 2000; 14: 52-56.
95. Singh S*, Singh N, H anda R. Tumour necrosis factor- alpha in patients with malaria. Indian J Malariol 2000; 37: 27-33. (IF: 0.9)
96. Singh S*, Mohapatra DP, Siva Kumar R. Successful replacement of foetal calf serum with human urine for in vitro culture of Leishmania donovani. J Commun Dis. 2000; 32:289-94.
97. Singh S*. Typhoid fever: Pathogenesis and Laboratory Diagnosis. J Indian Acad Clin Med 2001; 2:17-20
98. Singh S*, Mohanty A, Joshi YK, DekaD, DwivediSN. Outcome of hepatitis E virus infection in Indian pregnant women admitted to a tertiary care hospital. Indian J Med Res 2001; 113: 35-39. (IF: 1.6)
99. Aggarwal P, Wali JP, Singh S*,H anda R, Wig N, Biswas A. A Clinico-Bacteriological study of peripheral tuberculous lymphadenitis. J Assoc Phys India 2001; 49: 808-12.
100. Sivakumar R, Singh N, Singh S*. Nested polymerase chain reaction in the diagnosis of congenital Cytomegalovirus infection. Indian J Pediatr 2001; 68: 1043-46. (IF: 0.92)
101. Singh S*, Mohanty A, Joshi YK, Deka D, Mohanty S, P anda SK. Hepatitis E virus infection carries high fatality rate in Indian pregnancies. eBMJ; 2001; 322:151. (IF: 3.592)
102. Kaur M, Sivakumar R, Singh S*. Current trends in the laboratory diagnosis of tuberculosis- an overview. J Lab Med 2002; 3: 6-11.
103. Singh S*. Human Strongyloidiasis in AIDS Era: Its Zoonotic importance. Review article. J Assoc Phys India 2002; 50: 415-422.
104. Singh S*. Prevalence of TORCH infections in pregnant women. Indian J Med Microb 2002; 20: 57-58. (IF: 0.75)
105. Singh S*. High prevalence of viral and other sexually transmitted diseases in Indian prisons. BMJ 2002; 324: 850. (IF: 9.2)
106. Singh S*, Veena Kumari, Singh N. Predicting Kala-Azar Disease Manifestations in Asymptomatic Patients with Latent Leishmania donovani Infection by Detection of Antibody against Recombinant K39 Antigen. Clin Diagn Lab Immunol 2002; 9: 568-72. (IF: 2.09)
107. Anonymous. Diagnosing and treating Leishmaniasis. Lancet Infectious Diseases, 2002; 2: 264. (IF: 8.5)
108. Singh B.A, Shashi Kant, Singh S*, Kapoor SK. Seroprevalence of Toxoplasma infection among primigravid women attending antenatal clinic at a secondary level hospital in North India. J Indian Med Assoc, 2002; 100; 591-97.
109. Singh S*. Food scarcity and HI/AIDS epidemic in India. 2002. www.indev.org/articles/foodsecurity_hiv.html.
110. Trajkovic V, Singh G, Singh B, Singh S*, and Sharma P. Effect of Mycobacterium tuberculosis-Specific 10-Kilodalton Antigen on Macrophage Release of Tumor Necrosis Factor Alpha and Nitric Oxide. Infect Immun2002; 70 (12): 6558-6566. (IF: 4.004)
111. Singh S*.Systemic versus local medication of vulvo-vaginal infections. eBMJ. 2002; 325:586. (IF: 3.52)
112. Singh S*, Mohanty A, Joshi YK, Deka D, Mohanty S, P anda SK. Mother-to-child transmission of hepatitis E virus infection. Indian J Paed, 2003; 70: 37-39. (IF: 0.9)
113. Natarajan K., LatchumananV.K., Singh B, Singh, S, and Sharma P. Maturation of dendritic cells by Mycobacterium tuberculosis specific antigen (MTSA) leads to down regulation of T helper responses to mycobacterial antigens. J Infect Dis. 2003; 187: 914-28. (IF: 6.2)
114. Bharathi MV, Basheer AM, Nedunchelliyan S, Singh S*,MeenachiSelven MS. Comparison of modified direct agglutination and indirect haemagglutination tests for detection of Toxoplasma gondii antibodies in goats in Chennai. J Vet Parasitol 2003; 17: 49-51. (IF: 0.7)
115. Singh S*. Herbal medicines put into context: Indian experience on using herbal medicines in AIDS therapy. BMJ 2003; 327:881.
116. Singh S*. Mother-to-child transmission and diagnosis of Toxoplasma gondii infection during pregnancy. Indian J Med Microbiol 2003; 21: 69-76. (IF: 0.9)
117. Singh S*. Sivakumar R. Recent Advances in the Diagnosis of Leishmaniasis. J Postgrad Med. 2003; 49:55-60. (IF: 1.2)
118. Singh S*. Leishmaniasis: diagnosing and treating the disease. BMJ 2003; 326:377.
119. Singh S*. Book Review. Indian J Med Microbiol 2003; 21:296-296. (IF: 0.9)
120. Singh S*. Human immunodeficiency virus transmitted through sheep brain anti-rabies vaccination. Vaccine. 2003; 21:4119. (IF: 3.00)
121. Singh S*. Food crisis and AIDS: Indian perspective. Lancet. 2003; 362: 1938-9. (IF: 22.2)
122. Singh S*.Laboratory Diagnosis of Congenital TORCH infections. J Lab Med 2003;4:6-22.
123. Kothari S, Sivakumar R, Singh S*. Absence of ∆32 mutation in CCR5 gene in a HIV-1 resistant Indian male spouse of an AIDS patient with 10 years unprotected exposure. J Lab Med 2003; 4: 28-32.
124. Singh S*.New strategies for increasing the detection of HIV: analysis of routine data. BMJ 2003; 326:1066.
125. Singh S*,Kumari V, Singh N. HIV-1 infection in a patient of acute lymphocytic leukaemia missed by HIV-spot and HIV-scan rapid tests. Indian J Med Microbiol 2004; 22: 64-65. (IF: 0.9)
126. Singh S*,Kaur Manjot. High rate of primary and acquired drug resistance in Indian Isolates of Mycobacterium tuberculosis. Int J Infect Dis, 2004; 8 (suppl. 1): S48. (IF: 2.2)
127. Singh S*, P andit AJ. Incidence and Prevalence of Toxoplasmosis in Indian pregnant women: A prospective study. Am J Reprod Immunol. 2004 Oct; 52(4):276-283. (IF: 3.2)
128. Singh S*.Mucosal Leishmaniasis in an Indian AIDS patient. Lancet Infect Dis, 2004; 4: 660-61.(IF: 16.2)
129. Singh S, Sivakumar R. Challenges and new discoveries in the Treatment of Leishmaniasis. Review. J Infect Chemother, 2004; 10 (6): 307-315. (IF: 1.52)
130. Shahdad S, Kaur M, Khattar S, Singh S*.A case of Pulmonary Mycobacterium celatum in an Indian AIDS Patient. Int J Infect Dis, 2005; 9 (1): 62-63. (IF: 2.32)
131. Singh S*, Dey A, Sivakumar R. Applications of Molecular Methods for Leishmania control. Expert Rev Mol Diagn. 2005; 5 (2): 251-65. (IF: 4.2)
132. Singh S*.Visceral Leishmaniasis: an opportunistic infection in HIV-infected patients. Lancet Infect Dis, 2005; 5: 197. (IF: 16.2)
133. Wig N, Anupama P, Singh S*,H anda R, Aggarwal P, Dwivedi SN, Jailkhani BL, Wali JP. Tumour Necrosis Factor-alpha Levels in Patients with HIV with Wasting in South Asia.AIDS Patient Care STDS. 2005 Apr;19(4):212-5. (IF: 2.52)
134. Singh S*, Sivakumar R. Polypeptides for the diagnosis and therapy of Leishmaniasis. PCT/IN03/00400. Expert Opinion on Therapeutic Patents, Volume 15, Number 10, 1 October 2005, pp. 1439-1465. (IF: 1.488)
135. Sivakumar R, Sharma P, Chang KP, Singh S*. Cloning, Expression and Purification of a Novel recombinant antigen from Leishmania donovani. Protein Expr Purif, 2006, 46:156-165. (IF: 1.7)
136. Singh S*. New Developments in diagnosis of leishmaniasis. Indian J Med Res, 2006; 123:311-330. (IF: 1.88)
137. Upadhyay A, Aggarwal R, Kapil A, Singh S*, Paul VK, Deorari AK. Profile of Neonatal Sepsis in a tertiary care neonatal Unit from India: A retrospective study. J Neonatol, 2006; 20: 50-57.
138. Redhu N S., Dey A, Balooni V, Singh S*. Leishmania-HIV Co-infection: An Emerging Problem in India. AIDS, 2006; 20 (8): 1213-15. (IF: 5.62)
139. Dey A,Singh S*. Transfusion Transmitted Leishmaniasis. Indian J Med Microbiol, 2006; 24: 165-170. (IF: 0.75)
140. Gupta S, Mathur P, Singh S*. Multiple opportunistic intestinal infections in a patient co-infected with Human Immunodeficiency Virus and hepatitis B virus- a case report. Trop Gastroenterol. 2006; 27 (2)): 97-98.
141. Redhu N S., Dey A, Balooni V, Singh S*. Use of Immunoglobulin G (IgG) Avidity to determine the course of Disease in Visceral and Post Kala-Azar Dermal Leishmaniasis. Clin Vaccine Immunol, 2006; 13 (8): 969-971. (IF: 2.02)
142. Dey A, Singh S*. Genetic heterogeneity among visceral leishmaniasis strains isolated from eastern India. Infection, Genetics & Evolution. 2007; 7: 219-222. (IF: 3.52)
143. Gupta S, Singh S*. Hepatitis B and C virus co-infections in HIV positive North Indian Patients. World J Gastroenterol 2006; 12 (42): 6879-83. (IF: 2.55)
144. Singh S*, Gopinath K, Shahdad S, Kaur M, Singh B, Sharma P. Non-tuberculous Mycobacterial Infections in Indian AIDS patients detected by a Novel set of ESAT-6 Polymerase Chain Reaction Primers. Jpn J Infect Dis., 2007, 60:14-18. (IF: 1.76)
145. Mishra J, Saxena A,Singh S*.Chemotherapy of Leishmaniasis: Past, present and future. Current Medicinal Chemistry, 2007; 14 (10): 1153-1169. (IF: 4.5)
146. Dey A, Sharma U, Singh S*. First case of indigenous visceral leishmaniasis from central India. Am J Trop Med Hyg, 2007: 77: 95-98. (IF: 2.54)
147. Gopinath K, Manisankar M, Kumar S, Singh S*. Controlling multidrug resistant tuberculosis in India. Lancet, 2007; 369: 741-42. (IF: 25.9)
148. Gopinath K, Kumar S, Manisankar M, Singh S*. A Novel Method for Clearing the Red Blood Cell debris from the BacT/ALERTTM Blood Culture Medium for Improved Microscopic and Anti-mycobacterial Drug Susceptibility Test Results. J Clin Lab Analys, 2007; 21:220-226. (IF: 1.52)
149. Sharma U, Redhu NS, Mathur P, Singh S*. Re-emergence of visceral leishmaniasis in Gujarat, India. J Vect Borne Dis, 2007; 44: 230-232.
150. Gupta S, Mathur P, Wig N, Singh S*. Immune Restoration Syndrome with Atypical manifestation of disseminated Penicillium marneffei and Cytomegalo Virus co- infections in an AIDS patient. AIDS Res Therapy, 2007 (8th October): e21 (IF: 1.45)
151. Singh S*, Sankar MM, Gopinath K. High rate of extensively drug resistant tuberculosis in Indian AIDS patients. AIDS, 2007; 21: 2345-47. (IF: 5.6)
152. Gupta S, Gupta R, Singh S*. Seroprevalence of HIV in pregnant women in North India: a tertiarycarehospital based study, BMC Infect Dis2007, 7:133 Nov. 15, 2007: doi: 10.1186/1471-2334-7-133. (IF: 2.62)
153. Gupta S, Gupta R, Singh S*.Role of Horizontal Transmission in Hepatitis B Virus Spread among Household Contacts in North India. Intervirology, 2008 51(1):7-13. (IF: 2.1)
154. Sivakumar R., Dey A, Sharma P, Singh S*. Expression and characterization of a recombinant kinesin antigen from an old Indian strain (DD8) of Leishmania donovani and comparing it with a commercially available antigen from a newly isolated (KE16) strain of L. donovani.Infec Genet Evol. 2008 (8): 313-322. PMID:18374635 (IF: 3.52)
155. Gupta S, Narang S, Nunavath V, Singh S*. Chronic diarrhoea in HIV patients: prevalence of coccidian Parasites. Indian J Med Microbiol, 2008; 26: 172-175. (IF: 0.9)
156. Dey A, Sharma P, Redhu NS, Singh S*. Kinesin Motor Domain of Leishmania donovani as future vaccine c andidate. Clin Vaccine Immunol. 2008; 15: 836-842. [doi:10.1128/CVI.00433-07] (IF: 2.02)
157. Gopinath K, Kumar S, Singh S*. Prevalence of mycobacteremia in Indian HIV infected patients detected by MB/BacT automated culture system. Eur J ClinMicrobiol Infect Dis, 2008; 27: 423-431. (IF: 3.52)
158. Grewal HM, Gupta S, Singh S*. Opportunistic pathogens in AIDS: trends, diagnosis and priorities. Expert Rev Anti Infect Ther. 2008 Apr; 6(2):163-6. (IF: 3.42)
159. Singh S*. Scalingup Anti-Mycobacterial Drug Susceptibility Testing Services in India: It is High time. Indian J Med Microbiol; 2008; 23:209-211.(IF: 0.9)
160. Kumar P, Srivatsava MV, Singh S*, Prasad HK. Filtration of CSF improves isolation of Mycobacteria. J Clin Microbiol. 2008, 46(8):2824-5. (IF: 4.02)
161. Sankar MM, Gopinath K, Singla R, Singh S*. In- vitro antimycobacterial drug susceptibility testing of Non-Tubercular Mycobacteria by Tetrazolium Microplate Assay. Ann Clin MicrobiolAntimicrob; 2008: Jul 11;7:15.(IF: 1.5)
162. Singh S*,Saluja TP, Kaur M, Khilnani GC. Comparative evaluation of Fast-Plaque assay with PCR and other conventional in-vitro diagnostic methods for the early detection of Pulmonary Tuberculosis. J Clin Lab Analys; 2008, 22 (5): 367-74. (IF: 1.45)
163. Singh S*,Balooni V, Singh N. Social and gender biases in HIV/AIDS care in India. Asian Pacific J Trop Med, 2008; 1 (3): 60-64.
164. Sharma U, Singh S*. Insect vectors of Leishmania: distribution, physiology and their control. J Vector Borne Dis 2008, 45; 255–272.
165. Sarda P, Sharma SK, Mohan A, Makharia G, Jayaswal A, P andey RM, Singh S*. Role of acute viral hepatitis as a confounding factor in antituberculosis treatment induced hepatotoxicity. Indian J Med Res. 2009;129: 64-67.(IF: 1.8)
166. Akhtar P, Singh S*,Bifani P, Kaur S, Srivastava BS, Srivastava R. Variable-number t andem repeat 3690 polymorphism in Indian clinical isolates of Mycobacterium tuberculosis and its influence on transcription. J Med Microbiol. 2009; 58:798-805. (IF: 2.5)
167. Sharma U, Singh S*. Immunobiology of Leishmaniasis. Indian J Exp Biology. 2009; 47: 412-23. (IF: 1.6)
168. M andal S, Maharjan M, Ganguly S, Chatterjee M, Singh S*, Buckner FS, Madhubala R. High Throughput screening of amastigotes of Leishmania donovani clinical isolates against drugs using a colorimetric β-lactamase assay. Indian J Exp Biology. 2009; 47 (6): 475-79. (IF: 1.6)
169. Gopinath K, Singh S*. Urine as an adjunct specimen for the diagnosis of active pulmonary tuberculosis. Int J Infect Dis 2009; 13 (3): 374-379. (IF: 2.5)
170. Gopinath K, Singh S*. Multiplex PCR Assay for Simultaneous Detection and Differentiation of Mycobacterium tuberculosis, M. avium Complexes, and Other Mycobacterial Species Directly from Clinical Specimens. J Applied Microbiol, 2009; 107: 425-35 (IF: 2.56)
171. Dey A, Kumar U, Sharma P, Singh S*.Immunogenicity of c andidate chimeric DNA vaccine against tuberculosis and leishmaniasis. Vaccine, 2009; 27: 5152–5160. (IF: 3.0)
172. Dey A, Singh S*.Progress of Science from Microscopy to Microarrays. (Part 1): Diagnosis of Parasitic Diseases. J Lab Physic, 2009; 1 :2-6
173. Goswami R, Somvanshi R, Singh SM, Singh S*. A preliminary survey on incidence of helminthic and protozoal diseases in rats. Indian J Vet Pathol, 2009; 33: 90-92.
174. Kumar P, Nath K, Rath B, Sen MK, Vishalakshi P, Chauhan DS, Katoch VM, Singh S, Tyagi J, Sreenivas V, Prasad HK. Visual Format for Detection of Mycobacterium tuberculosis and M. bovis in Clinical Samples Using Molecular Beacons. J Mol Diagn, 2009; 11: 430-438. (IF: 3.478)
175. Sharma SK, Singla R, Sreenivas V, Kumar S, Jha B, Rathore J, Singh S. Acute viral hepatitis as a confounding factor in patients with antituberculosis treatment induced hepatotoxicity. Indian J Med Res. 2009; 130:200-201. (IF: 1.8)
176. Sankar MM, Kumar P, Munawwar A, Singh J, Parashar D, Singh S*. Recovery of M. tuberculosis from sputum treated with Cetyl Pyridinium Chloride. J Clin Microbiol. 2009; 47(12):4189-90. (IF: 3.4)
177. Sharma S, Chanana B, Gulati S, Venkatesh P, Singh S*. Acute bilateral vision loss as the presenting feature of subacute sclerosing panencephalitis. Indian J Pediatr. 2009; 76: 952-3. (IF: 0.9)
178. Kumar V, Hassan M I, Tomar A K, Kashav T, Nautiyal J, Singh S, Singh T P and Yadav S. Proteomic analysis of heparin-binding proteinsfrom human seminal plasma: a step towards identification of molecular markers of male fertility; J. Biosci. 2009; 34: 899–908. (IF: 0.9)
179. Singhal V, Bora D, Singh S*. Hepatitis B in Health Care Workers: Indian Scenario. J Lab Physic 2009; 1 (2): 41-48.
180. Singh S*,Munawwar A. Human toxoplasmosis: A food borne Parasitic Disease. Proc. Nat Acad Sci. India. 2009; 79 (sp issue): 207-220.
181. Sharma U., Velp andian T., Sharma P, Singh S*. Evaluation of anti-leishmanial activity of selected Indian plants known to have antimicrobial properties. Parasitol Res 2009: 105; 1287-1293. (IF: 1.4)
182. M andal S, Maharjan M, Singh S, Chatterjee M, Madhubala R. Assessing Aquaglyceroporin Gene Status and Expression Profile in Antimony- Susceptible and Resistant Clinical Isolates of L. donovani from India. J Antimicrob Chemo. 2010 Mar;65(3):496-507. (IF: 5.4)
183. Sharma SK, Singla R, Sarda P, Mohan A, Makharia G, Jayaswal A, Sreenivas V, Singh S. Safety of different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity. Clin Infect Dis. 2010; 50:833-9. (IF: 9.8)
184. Kumar D, Nath L, Kamal MA, Varshney A, Jain A, Singh S, Rao KVS. Genome-Wide Analysis of the Host Molecular Network that regulates Intracellular Survival of Mycobacterium tuberculosis. Cell. 2010 Mar 5; 140(5):731-743. (IF: 31.2)
185. Gupta S, Singh S*. Occult Hepatitis B Virus infection in ART-Naive HIV-Infected Patients seen at a Tertiary Care Centre in North India. BMC Infect Dis. 2010; 10 (1):53. (IF: 2.4)
186. Gopinath K, Singh S*.Non-tubercular Mycobacteria in TB Endemic Countries: Are we neglecting the danger? PLoS- NTD, 2010 April; 4 (4): e615 (IF: 5.3)
187. Kumar P, Sen M.K., Chauhan D.S., Katoch V.M, Singh S, Prasad H.K. Assessment of the N-PCR assay in the diagnosis of pleural tuberculosis: Detection of Mycobacterium tuberculosis in pleural fluid and sputum samples collected in t andem.PLoS ONE; 2010; 5(4): e10220. (IF: 3.1)
188. Mishra J, Carpenter S, Singh S*. Low serum zinc levels in an endemic area of visceral leishmaniasis in Bihar, India. Indian J Med Res, 2010, 131: 793-98. (IF: 1.8)
189. Singla R, Sharma SK, Mohan A, Makharia G, Sreenivas V, Jha B, Kumar S, Sarda P, Singh S. Evaluation of risk factors for antituberculosis treatment induced hepatotoxicity. Indian J Med Res, 2010, 132: 81-86. (IF: 1.8)
190. Raghuvanshi S. Sharma P, Singh S,Kaer LV, Das G. Mycobacterium tuberculosis evades host immunity by recruiting mesenchymal stem cells. PNAS, 2010; 107: 21653-58. (IF: 9.8).
191. Singh S*. Journal of Laboratory physicians (JLP): Success Story despite many challenges. J Lab Physicians. 2011 Jan;3(1):1-3.
192. Yadav VK, Kumar V, Chhikara N, Kumar S, Manral P, Kashav T, Saini S, Srinivasan A, Singh S, Singh TP, Yadav S. Purification and Characterization of native zinc-binding molecular weight multiprotein complex from human seminal plasma. J Sep Sci. 2011; 34(9):1076-83.
193. Singhal V, Bora D,Singh S*.Prevalence of Hepatitis B Virus Infection in Healthcare Workers of a Tertiary Care Centre in India and Their Vaccination Status. J Vaccine Vaccinol. 2011; 2:2: 1-4.
194. Singh S*. Sharma U, Mishra J. Post-kala-azar-dermal Leishmaniasis in India: recent developments. Int J Dermatol. 2011; 50 (9): 1099-1108.( IF: 1.5)
195. Singh S*.Katoch VM. Commercial Serological tests for the diagnosis of active tuberculosis in India: time to introspection. Indian J Med Res. 2011; 134: 583-587. (IF: 1.8)
196. Sharma U, Singh D, Kumar P, Dobhal MP,Singh S*. Antiparasitic activity of Plumericine&isoplumericin isolated from Plumeria bicolor against Leishmania donovani. Indian J Med Res. 2011; 134: 709-716. ( IF: 1.8)
197. Sumatoh HR, Oliver BG, Kumar M, Elliott JH, Vonthanak S, Vun MC, Singh S, Agarwal U, Kumar A, Tan HY, Kamarulzaman A, Yunihastuti E, Saraswati H, Price P. Mycobacterial antibody levels and immune restoration disease in HIV patients treated in South East Asia. Biomark Med. 2011 Dec; 5(6):847-53. (IF: 2.64)
198. Singh D, Sharma U, Kumar P, Gupta YK, Dobhal MP,Singh S*.Antifungal activity of plumericin and isoplumericin. Natural Product Commun; 2011; 6 (11): 1567-68. (IF: 0.8)
199. Singh S*, Gopinath K. Mycobacterium avium subspecies Paratuberculosis and crohn’s regional ileitis: How strong is association? J Lab Physicians. 2011; 3 (2): 69-74.
200. Tomar AK, Sooch BS, Raj I, Singh S, Singh TP, Yadav S. Isolation and identification of Concanavalin A binding glycoproteins from human seminal plasma: A step towards identification of male infertility marker proteins.Dis Markers. 2011 Jan 1; 31(6):379-86. (IF: 1.56)
201. Lisco A, Munawwar A, Introini A, Vanpouille C, Saba E, Feng X, Grivel JC, Singh S*, Margolis L. Semen of HIV-1 Infected individuals: local shedding of Herpes viruses and Reprogrammed Cytokine Network. J Infect Dis. 2012; 205 (1): 97-105. ( IF: 6.2)
202. Kumar V, Yadav VK, Hassan I, Singh AK, Dey S, Singh S, Singh TP, Yadav S. Kinetic and Structural Studies on the Interactions of Heparin and Proteins of Human Seminal Plasma using Surface Plasmon Resonance.ProteinPept Lett. 2012; 19 (8):795-803. (IF: 1.07)
203. Tomar AK, Sooch BS, Singh S, Yadav S. Quantification studies in human seminal plasma samples identify prolactin inducible protein as a plausible marker of azoospermia. Biomarkers. 2012; 17 (6): 545-51.( IF: 2.2)
204. Tomar AK, Sooch BS, Singh S, Yadav S. Differential proteomics of human seminal plasma: A potential target for searching male infertility marker proteins. Proteomics Clin Appl. 2012; 6:147-51. ( IF: 2.96)
205. Price P, Haddow LJ, Aff andi J, Agarwal U, Easterbrook PJ, Elliott J, French M, Kumar M, Moosa MY, Oliver B, Singh S, et al. Plasma Levels of Vitamin D in HIV Patients Initiating Antiretroviral Therapy Do Not Predict Immune Restoration Disease Associated with Mycobacterium tuberculosis.AIDS Res Hum Retroviruses. 2012; 28 (10) 1216-9. (IF: 2.58)
206. Kumar S, Tomar AK, Singh S, Saraswat M, Singh S*, Singh TP, Yadav S. Human serum albumin as a new interacting partner of prolactin inducible protein in human seminal plasma.Int J BiolMacromol. 2012; 50(2):317-22. (IF: 2.858)
207. Munawwar A, Singh S*.AIDS associated Tuberculosis: a catastrophic collision to evade the host immune system. Tuberculosis. 2012; 92 (5):348-7. [DOI: 10.1016/j.tube.2012.05.006] (IF: 3.5)
208. Singh S*, Kumar P, Sharma S, Mumbowa F, Martin A, Durier N. Rapid Identification and Drug Susceptibility Testing of Mycobacterium tuberculosis: St andard Operating Procedure for Non-Commercial Assays: Part 3: Colorimetric Redox Indicator Assay v1.3.12. J Lab Physicians. 2012 Jul; 4(2):120-6.
209. Singh S*, Kumar P, Sharma S, Mumbowa F, Martin A, DurierN.Rapid Identification and Drug Susceptibility Testing of Mycobacterium tuberculosis: St andard Operating Procedure for Non-Commercial Assays: Part 2: Nitrate Reductase Assay v1.3.12. J Lab Physicians. 2012 Jul; 4(2):112-9.
210. Singh S*, Kumar P, Sharma S, Mumbowa F, Martin A, DurierN.Rapid Identification and Drug Susceptibility Testing of Mycobacterium tuberculosis: St andard Operating Procedure for Non-Commercial Assays: Part 1: Microscopic Observation Drug Suceptibility Assay v2.4.12. J Lab Physicians. 2012 Jul; 4(2):101-11.
211. Singh S*, Singh, J, Kumar S, Gopinath K, Balooni V, Singh N, Mani K. Poor Performance of Serological Tests in the Diagnosis of Pulmonary Tuberculosis: Evidence from a Contact Tracing Field Study. PLoS ONE 2012. http://dx.plos.org/10.1371/journal.pone.0040213(IF: 3.78)
212. Lagrange PH, Thangaraj SK, Dayal R, Desp ande A, Ganguly NK, Girardi E, Joshi B, Katoch K, Katoch VM, Kumar M, Lakshmi V, Leportier M, Longuet C, Malladi SV, Mukerjee D, Nair D, Raja A, Raman B, Rodrigues C, Sharma P, Singh A, Singh S, et al. A toolbox for tuberculosis diagnosis: an Indian multicentric study (2006-2008) microbiological result. PLoS One. 2012; 7(8):e43739. Doi: 10.1371/journal.pone.0043739. (IF: 3.78)
213. N andan D; Bhatt GC; DewanV; Yadav TP; Singh S*.Isolated tuberculous liver abscess in a 3-year old immunocompetent child. Paediatr Int Child Health. 2013; 33(3): 187-189.(IF: 1.08)
214. Jayakumar R., Joshi YK, Singh S*. Laboratory Evaluation of Three Regimens of Treatment of Chronic Hepatitis B: Tenofovir, Entecavir and Combination of Lamivudine and Adefovir. J Lab Physicians 2012; 4(1):10-6.
215. Kumar V, Yadav VK, Hassan I, Singh AK, Dey S, Singh S, Singh TP, Yadav S. Kinetic and Structural Studies on the Interactions of Heparin and Proteins of Human Seminal Plasma using Surface Plasmon Resonance.ProteinPept Lett. 2012; 19(8):795-803. (IF: 1.98)
216. Lagrange PH ,Thangaraj SK, Dayal R , Desp ande A, Ganguly NK, Girardi E, Joshi B , Katoch K , Katoch VM , Kumar M, Lakshmi V, Leportier M , Longuet C, Subbalaxmi V. S. M, Mukerjee D, Nair D, Raja A, Raman B, Rodrigues C, Sharma P, Singh A, Singh S, Sodha A, Kabeer BSA, Vernet G, Goletti D. A Toolbox for Tuberculosis Diagnosis: An Indian Multicentric Study (2006-2008): Microbiological Results. PLoS ONE 2012; 7(8): e43739. doi:10.1371/journal.pone.0043739 (IF: 3.78)
217. Singh S*, Sankar MM, Kumar M, Sharma SK, Disseminated Tuberculosis Caused by a Rare and Multidrug Resistant “Beijing” Genotype of Mycobacterium tuberculosis. Chest, 2012; 142: 253A-253A. doi:10.1378/chest.1388948 (IF: 5.08)
218. Magee MJ, Blumberg HM, Broz D, Furner SE, Samson L, Singh S, Hershow RC. Prevalence of drug resistant tuberculosis among patients at high risk for HIV attending out patient clinics in Delhi, India. Southeast Asian J Trop Med Public Health. 2012; 43(2):354-63.
219. Lisco A, Introini A, Munawwar A, Vanpouille C, Grivel JC, Blank P, Singh S*, Margolis L. HIV-1 imposes rigidity on Blood and semen cytokine network. Am J Reprod Immunol. 2012; 68 (6): 515-21. Doi: 10.1111/aji.12015. (IF: 3.08)
220. Chhikara N, Saraswat M, Tomar AK, Dey S, Singh S, et al. Human Epididymis Protein-4 (HE-4): A Novel Cross-Class Protease Inhibitor. PLoS ONE 2012; 7(11): e47672. doi:10.1371/journal.pone.0047672 (IF: 3.78)
221. Tomar AK, Sooch BS, Raj I, Singh S, Yadav S. Interaction analysis identifies semenogelin I fragments as new binding partners of PIP in human seminal plasma. Int J BiolMacromol. 2013; 52: 296-99 doi: 10.1016/j.ijbiomac.2012.10.011. (IF: 2.85)
222. Sankar MM, Balooni V, Singh J, Singh S*.Diagnostic performance of commercially available enzyme-linked immunosorbent assay kit in the diagnosis of extrapulmonary tuberculosis. J Lab Physicians. 2013 Jan; 5(1):11-6. Doi: 10.4103/0974-2727.115902.
223. Singh N, Mishra J, Singh R, Singh S*. Animal Reservoirs of Visceral Leishmaniasis in Bihar, India. J Parasitol. 2013; 99: 64-7. (IF: 1.5)
224. Sankar MM, Kumar P, Munawwar A, Kumar M, Singh J, Singh A, Parashar D, Malhotra N, Duttagupta S, Singh S*.Usefulness of multiplex PCR in the diagnosis of genital tuberculosis in females with infertility. Eur J Clin Microbiol Infect Dis. 2013; 32(3):399-405 PMID:23052988 (IF: 3.18)
225. Mishra J, Madhubala R, Singh S*. Visceral and Post Kala-Azar Dermal Leishmaniasis isolates show significant difference in their in-vitro drug susceptibility pattern. Parasitology Research. 2013; 112(3):1001-9. (IF: 2.18)
226. Tomar AK, Sooch BS, Singh S, Yadav S. Aggregation analysis of Con abinding proteins of human seminal plasma: A dynamic light scattering study. Int J BiolMacromol. 2013; 53:133-7. (IF: 2.85)
227. Bhatt GC, N andan D, Singh S. Isolated tuberculous liver abscess in immunocompetent children-Report of two cases. Pathog& Glob Health. 2013; 107(1):35-37. doi:10.1179/2047773212Y.0000000071 (IF: 0.85)
228. Jain S, Singh S, Sankar MM, Saha R, Rangaraju RR, Chugh TD. Catheter-related bacteremia due to M. chelonae in an immunocompromised patient: an emerging nosocomial pathogen. Indian J Med Microbiol. 2012; 30(4):489-91. (IF: 1.05)
229. Yadav VK, Chhikara N, Gill K, Dey S, Singh S, Yadav S. Three low molecular weight cysteine proteinase inhibitors of human seminal fluid: Purification and enzyme kinetic properties. Biochimie. 2013; 95(8):1552-59. Doi: pii: S0300-9084(13)00111-9. (IF: 3.123)
230. Yadav VK, Saraswat M, Chhikara N, Singh S, Yadav S. Heparin and heparin Binding proteins: potential relevance to reproductive physiology. Curr Protein Pept Sci. 2013 Feb 1; 14(1):61-9. (IF: 3.10)
231. Mathur P, Singh S*. Multidrug Resistance in Bacteria: A Serious Patient Safety Challenge for India. J Lab Physicians. 2013 Jan;5(1):5-10.
232. Kumar P, Singh A, Sharma U, Singh D, Dobhal MP, Singh S*. Anti-mycobacterial activity of plumericin and isoplumericin against MDR Mycobacterium tuberculosis. PulmPharmacolTher. 2013 Jun; 26(3):332-5. (IF: 2.563)
233. Tomar AK, Sooch BS, Raj I, Singh S, Yadav S. Interaction analysis identifies semenogelin I fragments as new binding partners of PIP in human seminal plasma. Int J BiolMacromol. 2013; 52:296-9. (IF: 2.85)
234. Sankar MM, Singh J, Diana SC, Singh S*. Molecular characterization of Mycobacterium tuberculosis isolates from North Indian patients with extra-pulmonary tuberculosis. Tuberculosis (Edinb). 2013; 93(1):75-83. (IF: 3.5)
235. Mishra J, Dey A, Singh N, Somvanshi R, Singh S*. Evaluation of toxicity and therapeutic efficacy of a new liposomal formulation of Amphotericin B in mice model by real time PCR. Indian J Med Res. 2013; 137: 767-776. (IF: 2.05)
236. Singh J, Sankar MM, Kumar S, Gopinath K, Singh N,Mani K, Singh S*. Incidence and prevalence of tuberculosis among household contacts of pulmonary tuberculosis patients in a Peri-urban population of South Delhi, India. PLoS One. 2013; 8 (7) e69730. doi:10.1371/journal.pone.0069730. (IF: 3.785)
237. Das S, Roychowdhury T, Kumar P, Kumar A, Kalra P, Singh J, Singh S, Prasad H, Bhattacharya A. Genetic Heterogeneity revealed by sequence analysis of Mycobacterium tuberculosis isolates from extra-pulmonary tuberculosis patients. BMC Genomics, 2013: June 17: 14 (1): 404. (IF: 5.85)
238. Yadav VK, Saraswat M, Chhikara N, Singh S, Yadav S.Heparin and heparin binding proteins: potential relevance to reproductive physiology. Curr Protein Pept Sci. 2013 Feb; 14(1):61-9. (IF: 3.10)
239. Mishra J, Madhubala R, Singh S*.Visceral and post-Kala-Azar dermal leishmaniasis isolates show significant difference in their in vitro drug susceptibility pattern. Parasitol Res. 2013 Mar; 112(3):1001-9. Doi: 10.1007/s00436-012-3222-1. Epub 2012 Dec 18. (IF: 2.15)
240. Oliver BG, HaddowLJ, Agarwal U, Kumar M, Easterbrook PJ, Moosa MY, Singh S, Price P.Pre-antiretroviral therapy plasma levels of CCL2 may aid in the prediction of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV patients after they commence antiretroviral therapy. J Acquir Immune DeficSyndr. 2013 Jun 1;63(2):e72-4. doi: 10.1097/QAI.0b013e31828e6182. (IF: 4.556)
241. Aff andiJS, Kumar M, Agarwal U, Singh S, Price P.The search for a genetic factor associating with immune restoration disease in HIV patients co-infected with Mycobacterium tuberculosis. Dis Markers. 2013; 34(6):445-9. Doi: 10.3233/DMA-130991. (IF: 2.65)
242. Parashar D, Kabra SK, Lodha R, Singh V, Mukherjee A, Arya T, Grewal HM, Singh S*; Delhi Pediatric TB Study Group. Does neutralization of gastric aspirates from children with suspected intrathoracic tuberculosis affect mycobacterial yields on MGIT culture? J ClinMicrobiol. 2013 Jun;51(6):1753-6. doi: 10.1128/JCM.00202-13. (IF: 4.115)
243. Kumar P, Rufai SB, Singh S*. Heat fixed but unstained slide smears are infectious to laboratory staff. Indian J Tuberc. 2013 Jul;60(3):142-6.
244. Singh S*. Bio-safety precautions in tuberculosis laboratory. Indian J Tuberc. 2013 Jul; 60(3):135-7.
245. Yadav VK, Chhikara N, Gill K, Dey S, Singh S. Yadav S. Three low molecular weight cysteine proteinase inhibitors of human seminal fluid: purification and enzyme kinetic properties. Biochimie. 2013 Aug;95(8):1552-9. doi: 10.1016/j.biochi.2013.04.007. (IF: 3.15)
246. Lagrange PH, Thangaraj SK, Dayal R, Deshp ande A, GangulyNK, Girardi E, Joshi B, Katoch K, Katoch VM, Kumar M, Lakshmi V, Leportier M, Longuet C, MalladiSV, Mukerjee D, Nair D, Raja A, Raman B, Rodrigues C, Sharma P, Singh A, Singh S.Sodha A, Kabeer BS, Vernet G, Goletti D. A toolbox for tuberculosis (TB) diagnosis: an Indian multicentric study (2006-2008). Evaluation of QuantiFERON-TB gold in tube for TB diagnosis. PLoS One. 2013 Sep 6;8(9):e73579. doi: 10.1371/journal.pone.0073579. (IF: 3.57)
247. Mishra J, Singh S*. Miltefosine resistance in Leishmania donovani involves suppression of oxidative stress-induced programmed cell death. Exp Parasitol. 2013;135(2):397-406. doi:10.1016/j.exppara.2013.08.004. (IF: 2.15)
248. Mukherjee A, Singh S, Lodha R, Singh V, Hesseling AC, Grewal HM, Kabra SK; Delhi Pediatric TB Study Group. Ambulatory Gastric Lavages Provide Better Yields of Mycobacterium tuberculosis Than Induced Sputum in Children with Intrathoracic Tuberculosis. Pediatr Infect Dis J. 2013 Dec;32(12):1313-7. doi: 10.1097/INF.0b013e31829f5c58. (IF: 2.75)
249. Mukherjee A, Saini S, Kabra SK, Gupta N, Singh V, Singh S, Bhatnagar S, Saini D, Grewal HM, Lodha R; Delhi TB Study group. Effect of micronutrient deficiency on QuantiFERON-TB Gold In-Tube test and tuberculin skin test in diagnosis of childhood intrathoracic tuberculosis. Eur J Clin Nutr. 2014 Jan;68(1):38-42. doi: 10.1038/ejcn.2013.216. (IF: 2.95)
250. Singh S*. Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States. eBMJ 2014;348:g3656
251. Kumar P, Balooni V, Sharma BK, Kapil V, Sachdeva KS, Singh S*. High degree of multi-drug resistance and hetero-resistance in pulmonary TB patients from Punjab state of India.Tuberculosis (Edinb). 2014 Jan;94(1):73-80. doi: 10.1016/j.tube.2013.10.001. (IF: 3.5)
252. Singh S*, Munawwar A, Rao S, Mehta S, Hazarika NK. Serologic prevalence of Toxoplasma gondii in Indian women of child bearing age and effects of social and environmental factors. PLoSNegl Trop Dis. 2014 Mar 27;8(3):e2737. doi: 10.1371/journal.pntd.0002737(IF: 4.45)
253. Behera B, Mathur P, Bhardwaj N, Jain N, Misra MC, Kapil A, Singh S. Antibiotic susceptibilities, streptococcal pyrogenic exotoxin gene profiles among clinical isolates of group C or G Streptococcus dysgalactiae subsp. equisimilis& of group G Strep. anginosus group at a tertiary care centre. Indian J Med Res. 2014 Mar; 139(3):438-45. (IF: 1.85)
254. Mathur P, Bhardwaj N, Mathur K, Behera B, Gupta G, Kapil A, Singh S. Clinical and molecular epidemiology of beta-haemolytic streptococcal infections in India. J Infect Dev Ctries. 2014; 8 (3): 297-303. (IF: 1.55)
255. Jain S, Sankar MM, Sharma N, Singh S, Chugh TD. High prevalence of non-tuberculous mycobacterial disease among non-HIV infected individuals in a TB endemic country–experience from a tertiary center in Delhi, India. Pathog Glob Health. 2014 Mar;108(2):118-22. doi: 10.1179/2047773214Y.0000000133. (IF: 1.05)
256. Satyaraddi A, Velp andian T, Sharma SK, Vishnubhatla S, Sharma A, Sirohiwal A, NakhariaGK, Sinha S, Biswas A, Singh S*.Correlation of plasma anti-tuberculosis drug levels with subsequent development of hepatotoxicity. Int J Tub Lung Dis, 2014; 18 (2): 188-195. (IF: 2.35)
257. Singh A, Gopinath K, Singh N, Singh S*. Deciphering the sequential events during in-vivo acquisition of drug resistance in Mycobacterium tuberculosis. Int J Mycobacteriol 2014; 3 (1): 36-40.
258. Singh S*. Commentary: Slow or long term on-progressor HIV patients: Indian scenario. Indian J Med Microbiol 2014; 32 (1): 77-78. (IF: 1.85)
259. Kumar P, Benny P, Jain M, Singh. Comparison of an in-house multiplex PCR with two commercial immunochromatographic tests for rapid identification and differentiation of MTB from NTM isolates. Int J Mycobacteriol 2014; 3 (1): 50-56.
260. Lagrange PH, Thangaraj SK, Dayal R, Deshp ande A, Ganguly NK, Girardi E, Joshi B, Katoch K, Katoch VM, Kumar M, Lakshmi V, Leportier M, Longuet C, Malladi SV, Mukerjee D, Nair D, Raja A, Raman B, Rodrigues C, Sharma P, Singh A, Singh S,Sodha A, Kabeer BS, Vernet G, Goletti D. A Toolbox for Tuberculosis (TB) Diagnosis: An Indian Multi-Centric Study (2006-2008); Evaluation of Serological Assays Based on PGL-Tb1 and ESAT-6/CFP10 Antigens for TB Diagnosis. PLoS One. 2014 May 5;9(5):e96367. doi: 10.1371/journal.pone.0096367. (IF: 3.77)
261. Rufai SB, Kumar P, Singh A, Prajapati S, Balooni V, Singh S*. Comparison of Xpert MTB/RIF with Line Probe Assay for Detection of Rifampin-Monoresistant Mycobacterium tuberculosis. J Clin Microbiol. 2014 Jun;52(6):1846-52. doi: 10.1128/JCM.03005-13. (IF: 4.232)
262. N andan D, Nag VK, Trivedi N, Singh S*. X-linked Hyper-IgM Syndrome with Bronchiectasis. J Lab Physicians. 2014 Jul;6(2):114-6. doi: 10.4103/0974-2727.141510.
263. Singh S*, Rufai SB, Kumar P, Singh J. Reply to “molecular diagnosis of rifampin-monoresistant tuberculosis in Indian patients: problems with a discordance analysis”. J Clin Microbiol. 2014 Sep;52(9):3504-5. doi: 10.1128/JCM.01731-14. (IF: 4.2325)
264. N andan D, Jahan A, Dewan V, Singh S, Buxi G. Pure red cell aplasia in a three-months-old infant possibly secondary to cytomegalo virus infection. Indian J Hematol Blood Transfus. 2014 Sep;30 (Suppl 1):30-2. doi: 10.1007/s12288-012-0226-z. (IF: 0.05)
265. Kh andelwal D, Gupta N, Mukherjee A, Lodha R, Singh V, Grewal HM, Bhatnagar S, Singh S, Kabra SK; Delhi Pediatric TB Study Group. Vitamin D levels in Indian children with intrathoracic tuberculosis. Indian J Med Res. 2014 Oct;140(4):531-7. (IF: 1.85)
266. Lodha R, Mukherjee A, Singh V, Singh S, Friis H, Faurholt-Jepsen D, Bhatnagar S, Saini S, Kabra SK, Grewal HM; Delhi Pediatric TB Study Group. Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a r andomized controlled trial. Am J Clin Nutr. 2014 Nov;100(5):1287-97. (IF: 6.95)
267. Singh S*. Early detection of multi-drug resistant tuberculosis in India using GenoTypeMTBDRplus assay & profile of resistance mutations in Mycobacterium tuberculosis. Indian J Med Res. 2014 Oct;140(4):477-9. (IF: 1.85)
268. Kumar P, P andya D, Singh N, Behera D, Aggarwal P, Singh S*. Loop-mediated isothermal amplification assay for rapid and sensitive diagnosis of tuberculosis. J Infect. 2014 Dec; 69(6):607-15. doi: 10.1016/j.jinf.2014.08.017. (IF: 4.55)
269. Mathew JL, Vijayasekharan D, Singh S*. Is Xpert MTB/RIF assay in gastric lavage aspirate useful for diagnosis of smear-negative childhood pulmonary tuberculosis? Indian Pediatr. 2014 Dec; 51(12):1007-11. (IF: 1.10)
270. Singh S*. Changing trends in the epidemiology, clinical presentation, and diagnosis of Leishmania-HIV co-infection in India. Int J Infect Dis. 2014 Dec; 29:103-12. doi: 10.1016/j.ijid.2014.07.011. (IF: 2.15)
271. Munawwar A, Sharma SK, Gupta S, Singh S*. Seroprevalence and determinants of Kaposi sarcoma-associated human herpesvirus 8 in Indian HIV-infected males. AIDS Res Hum Retroviruses. 2014 Dec;30(12):1192-6. doi: 10.1089/aid.2014.0184. (IF: 2.33)
272. Yadav VK, M andal RS, Puniya BL, Singh S, Yadav S. Studies on the interactions of SAP-1 (an N-terminal truncated form of cystatin S) with its binding partners by CD-spectroscopic and molecular docking methods. J Biomol Struct Dyn. 2015; 33(1):147-57. (IF: 2.69)
273. Singh A, Gopinath K, Sharma P, Bisht D, Sharma P, Singh N, Singh S*. Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant. Indian J Med Res 2015; 141 (1): 27-45. (IF: 1.60)
274. Pal R, Hameed S, Kumar P, Singh S, Fatima Z. Comparative Lipidome Profile of Sensitive and Resistant Mycobacterium tuberculosis Strain. Int J CurrMicrobiol App Sci.2015; 1: 189-197.
275. Singh S*, Dey B, Sachdeva KS, Kabra SK, Chopra KK, Chaudhary VK, Sharma P, Katoch VM. Challenges in tuberculosis diagnosis and management: recommendations of the expert panel.J Lab Physicians. 2015 Jan-Jun;7(1):1-3. doi: 10.4103/0974-2727.154778.
276. Singh S*, Kumar M, Singh P. Evolution of M. bovis BCG Vaccine: Is Niacin Production Still a Valid Biomarker? Tuberc Res Treat. 2015; 2015:957519. doi: 10.1155/2015/957519.
277. Nag VK, N andan D, Singh S, Arora SK, Tsanglao W, Arya N. Pulmonary Tuberculosis: A Predominant Cause of Childhood Bronchiectasis in India. J Commun Dis 2015; 47 (1): 14-18.
278. Yadav VK, M andal RS, Puniya BL, Kumar R, Dey S, Singh S, Yadav S. Structural and binding studies of SAP-1 protein with heparin. Chem Biol Drug Des. 2015 Mar; 85(3):404-10. doi: 10.1111/cbdd.12420. (IF: 2.485)
279. Singh S*. EPTB in Disdain: Indian Public Health Scenario. Eradicating TB in India. Global Policy, 2015; 3 (Spl): 56-61.
280. Kumar P, Kumar P, Balooni V, Singh S*. Genetic mutations associated with rifampicin and isoniazid resistance in MDR-TB patients in North-West India. Int J Tuberc Lung Dis. 2015;19(4):434-9. (IF: 2.85)
281. Greenl and K, Dixon R, Khan SA, Gunawardena K, Kihara JH, Smith JL, Drake L, Makkar P, Raman S, Singh S, Kumar S. The epidemiology of soil-transmitted helminths in Bihar State, India. PLoSNegl Trop Dis. 2015 May 20;9(5):e0003790. doi: 10.1371/journal.pntd.0003790. (IF: 4.446)
282. Sharma VK, Pai G, Deswarte C, Lodha R, Singh S, Kang LW, Yin CC, Casanova JL, Bustamante J, Kabra SK. Disseminated Mycobacterium avium complex infection in a child with partial dominant interferon gamma receptor 1 deficiency in India. J Clin Immunol. 2015 Jul;35(5):459-62. doi: 10.1007/s10875-015-0173-1. (IF: 3.15)
283. Gupta AK, Srivastava S, Singh A, Singh S*. De Novo Whole-Genome Sequence andAnnotation of a Leishmania Strain Isolated from a Case of Post-Kala-Azar Dermal Leishmaniasis. Genome Announc. 2015 Jul 16;3(4). pii: e00809-15. doi: 10.1128/genomeA.00809-15.
284. Singh S*. Can Establishment of Human Microbiome be Customized after Birth with Local Traditions of First Feed and Intimate Kissing? J Lab Physicians. 2015 Jul-Dec;7(2):73-4. doi: 10.4103/0974-2727.163140.
285. Singh J, Sankar MM, Kumar P, Couvin D, Rastogi N, Singh S*; Indian TB Diagnostics Network. Genetic diversity and drug susceptibility profile of Mycobacterium tuberculosis isolated from different regions of India. J. Infect. 2015 Aug;71(2):207-19. doi: 10.1016/j.jinf.2015.04.028. Epub 2015 Apr 29. (IF: 4.45)
286. Rufai SB, Singh A, Kumar P, Singh J, Singh S*. Performance of Xpert MTB/RIF assay in the diagnosis of pleural tuberculosis using pleural fluid samples. J Clin Microbiol. 2015 Nov;53(11):3636-8. doi: 10.1128/JCM.02182-15. (IF: 4.232)
287. Singh S*, Singh A, Prajapati S, Kabra SK, Lodha R, Mukherjee A, Singh V, Hesseling AC, Grewal HM; Delhi Pediatric TB study group. Xpert MTB/RIF assay can be used on archived gastric aspirate and induced sputum samples for sensitive diagnosis of paediatric tuberculosis. BMC Microbiol. 2015 Sep 29; 15:191. doi: 10.1186/s12866-015-0528-z. (IF: 2.79)
288. Rabodoarivelo MS, Imperiale B, Andrianiavomikotroka R, Br andao A, Kumar P, Singh S,Ferrazoli L, Morcillo N, Rasolofo V, Palomino JC, V andamme P, Martin A. Performance of Four Transport and Storage Systems for Molecular Detection of Multidrug-Resistant Tuberculosis. PLoS One. 2015;10(10):e0139382. doi: 10.1371/journal.pone.0139382. (IF: 3.57)
289. Drake LJ, Singh S, Mishra CK, Sinha A, Kumar S, Bhushan R, Hollingsworth TD, Appleby LJ, Kumar R, Sharma K, Kumar Y, Raman S, Chakrabarty S, Kihara JH, Gunawardena NK, Hollister G, Kumar V, Ankur A, Prasad B, Ramach andran S, Fishbane A, Makkar P. Bihar’s Pioneering School-Based Deworming Programme: Lessons Learned in Deworming over 17 Million Indian School-Age Children in One Sustainable Campaign.PLoSNegl Trop Dis.2015, 19;9(11):e0004106. doi: 10.1371/journal.pntd.0004106. (IF: 4.05)
290. Goel V, Kumar D, Kumar R, Mathur P, Singh S*. Community Acquired Enterococcal Urinary Tract Infections and Antibiotic Resistance Profile in North India. J Lab Physicians. 2016 Jan-Jun;8(1):50-4. doi: 10.4103/0974-2727.176237.
291. Munawwar A, Singh S*. Human Herpesviruses as co-pathogens of HIV Infection, Their Role in HIV Transmission, and Disease Progression. J Lab Physicians. 2016;8(1):5-18. doi: 10.4103/0974-2727.176228.
292. Saraswat M, Joenväärä S, Tomar AK, Singh S, Yadav S, Renkonen R. N-Glycoproteomics of Human Seminal Plasma Glycoproteins. J Proteome Res. 2016 Mar 4;15(3):991-1001. doi: 10.1021/acs.jproteome.5b01069. (IF: 4.17).
293. Jenum S, Dhanasekaran S, Lodha R, Mukherjee A, Kumar Saini D, Singh S, Singh V, Medigeshi G, Haks MC, Ottenhoff TH, Doherty TM, Kabra SK, Ritz C, Grewal HM. Approaching a diagnostic point-of-care test for paediatric tuberculosis through evaluation of immune biomarkers across the clinical disease spectrum. Nature Sc Rep, 2016 Jan 4;6:18520. doi: 10.1038/srep18520.(IF: 5.55).
294. Srivastava S, Shankar P, Mishra J, Singh S*. Possibilities and challenges for developing a successful vaccine for leishmaniasis. Parasite & Vectors. 2016 May 12; 9(1):277. (IF: 3.51).
295. Prajapati S, Upadhyay K, Mukherjee A, Kabra SK, Lodha R, Singh V, Grewal HM, Singh S*; Delhi Pediatric TB Study Group. High prevalence of primary drug resistance in children with intrathoracic tuberculosis in India. Paediatr Int Child Health. 2016; 36(3), 214-218 (IF: 1.05).
296. Singh S*. Congenital Toxoplasmosis: Clinical features, outcomes, treatment and prevention. Trop. Parasitol. 2016; 6(2): 113-122.
297. Tomar AK, Kumar S, Chhillar S, Kumaresan A, Singh S, Yadav S. Human Serum Albumin and Prolactin Inducible Protein Complex Enhances Serum Capacitation in-Vitro. J Proteins & Proteomics 2016; 7 (2), 107-113.
298. Goel V, Kumar D, Patwardhan V, Balooni V, Singhal S, Singh S. Trends of Seroprevalence. Epidemiology and Clincal presentation of HIV in North India: A tertiary Care Hospita Based Study. World J AIDS 2016; 6 (02), 54-58. (IF: 0.79).
299. Jenum, S., Bakken, R., Dhanasekaran, S., Mukherjee, A., Lodha, R., Singh, S., et al. BLR1 and FCGR1A transcripts in peripheral blood associate with the extent of intrathoracic tuberculosis in children and predict treatment outcome. Nature Sc Rep, 2016; 6, 38841. http://doi.org/10.1038/srep38841(IF: 5.55).
300. Goel V, Kumar D, Raghavendra L, Singh S*. Occurrence of Needlestick and Injuries among Health‑care Workers of a Tertiary Care Teaching Hospital in North India. J Lab Physicians 2017; 9 (1), 20-25. (IF: 0.67).
301. Rufai SB, Singh S*, Singh A, Kumar P, Singh J, Vishal A. Performance of Xpert MTB/RIF on Ascitic Fluid Samples for Detection of Abdominal Tuberculosis. J Lab Physicians 2017; 9 (1), 47-52. (IF: 0.67).
302. Saraswat M, Joenväärä S, Jain T, Tomar AK, Sinha A, Singh S, Yadav S, Renkonen R. Human spermatozoa quantitative proteomic signature classifies normo- and asthenozoospermia. Mol & Cell Proteomics 2017; 16 (1), 57-72. (IF: 5.91).
303. Raj V, Gupta V, Pathak M, Sreenivas V, Sood S, Singh S, Verma KK, Khanna N, Das BK, Gupta S. What puts them at risk? A cross-sectional case-control survey of demographic profile and sexual behaviour of patients with sexually transmitted infections at a tertiary care center in North India. Indian J STD AIDS, 2017; 38(1):22-36. DOI:10.4103/0253-7184.196885. (IF: 0.431).
304. Srivastava S, Mishra J, Gupta AK, Singh A, Mishra PS, Singh S*. Laboratory Confirmed Miltefosine Resistant Cases of Visceral Leishmaniasis from India. Parasites & Vectors, 2017; 10:49 DOI 10.1186/s13071-017-1969-z (IF: 3.41).
305. Singh A, Gupta A, Gopinath K, Sharma P, Singh S*. Evaluation of 5 Novel protein biomarkers for the rapid diagnosis of pulmonary and extra-pulmonary tuberculosis: preliminary results. Nature Sc Rep, 2017; 7:44121 (1-10). DOI: 10.1038/srep44121 (IF: 5.55).
306. Rufai SB, Singh A, Singh J, Kumar P, Sankar MM Singh S*. Diagnostic usefulness of Xpert MTB/RIF assay for detection of tuberculous meningitis using cerebrospinal fluid. J Infection. 2017; 75(2): 125-131. doi.org/10.1016/j.jinf.2017.04.010(IF: 4.441).
307. Wattal W, Javeri Y, Goel N, Dhar N, Saxena S, Singh S, Oberoi JK, et al. Convergence of Minds: For better patient outcome in intensive care unit infections.Indian J Crit Care Med 2017; 21, 154-159. (IF: 0.76).
308. Kumar P, Vats O, Kumar D, Singh S*. Coccidian intestinal parasites among immunocompetent children presenting with diarrhoea: Are we missing them? Trop Parasitol 2017; 7:37-40
309. Gupta AK, Singh A, Srivastava S, Singh S*. Visceral Leishmaniasis in Children: Diagnosis, Treatment, and Prevention. J Pediatr Infect Dis, July 2017;12(4):214-221.
310. Patwardhan V, Kumar D. Goel V, Singh S*. Parasitic Infections in Pediatric Population of India: Epidemiology, Diagnosis, and Strategies for Prevention. J Pediatr Infect Dis, 2017; 12(4):228-237.
311. Patwardhan V, Singh S*. Fosfomycin for the treatment of drug-resistant urinary tract infections: potential of an old drug not explored fully. Int UrolNephrol. 2017 Jun 14. doi: 10.1007/s11255-017-1627-6. (IF: 1.56).
312. Bhatnagar M, Sarkar N, G andharv N, Apang O, Singh S, Ghosal S. Evaluation of antimycobacterial, leishmanicidal and antibacterial activity of three medicinal orchids of Arunachal Pradesh, India. BMC Complement Altern Med. 2017 Aug 1;17(1):379. doi: 10.1186/s12906-017-1884-z. (IF: 2.228).
313. Patwardhan V, Kumar D. Goel V, Singh S*. Changing prevalence and antibiotic drug resistance pattern of pathogens seen in community‑acquired pediatric urinary tract infections at a tertiary care hospital of North India. J Lab physicians 2017; 9(4):264-268. . (IF: 0.67).
314. Pal R, Hameed S, Kumar P, Singh S, Fatima Z. Comparative lipidomics of drug sensitive and resistant Mycobacterium tuberculosis reveals altered lipid imprints. 3Biotech, 2017; 7:335.DOI: 10.1007/s13205-017-0972-6. (IF: 1.37).
315. Singh S*, Sankar MM. Diagnostic algorithms for low-volume CSF samples in tuberculous meningitis. Lancet Inf Dis, 2017; 17 (12): 1236-37. doi: 10.1016/S1473-3099(17)30639-4. (IF: 19.87).
316. Rufai, S.B., Singh, J., Kumar P., Mathur P., and Singh S.Association of gyrA and rrs gene mutations detected by MTBDRslV1 on Mycobacterium tuberculosis strains of diverse genetic background from India. Scientific reports June 2018;8(1) DOI: 10.1038/s41598-018-27299-z.
317. Pal R, Hameed S, Sabareesh V, Kumar P, Singh S, Fatima Z. Investigations into Isoniazid Treated Mycobacterium tuberculosis by Electrospray Mass Spectrometry Reveals New Insights into Its Lipid Composition.J Pathog. Jun 19;2018:1454316. doi: 10.1155/2018/1454316. eCollection 2018
318. Munawwar, A., Gupta, S., Sharma, S.K, and Singh, S. Seroprevalence of HSV-1 and 2 in HIV-infected males with and without GUD: Study from a tertiary care setting of India. J Lab Physicians. 2018 Jul-Sep;10(3):326-331. doi: 10.4103/JLP.JLP_7_18.
319. Sarkar N, Saha B, Singh S, Ghosal S. TropidiaCurculioides: Secondary metabolites and derivatives with antimycobacterial and leishmanicidal activity. Pharmacognosy Magazine. 2018 Oct 1;14(59):535.DOI: 10.4103/pm.pm_196_18.
320. Sinha A, Singh V, Singh S, Yadav S. Proteomic analyses reveal lower expression of TEX40 and ATP6V0A2 proteins related to calcium ion entry and acrosomal acidification in asthenozoospermic males. Life Sci. 2019 Feb 1;218:81-88. doi:10.1016/j.lfs.2018.12.016.
321. Rufai SB , Singh S .Whole-Genome Sequencing of Two Extensively Drug-Resistant Mycobacterium tuberculosis Isolates from India. Microbiol ResourcAnnounc. 2019Feb 14;8(7). pii: e00007-19. doi: 10.1128/MRA.00007-19
322. Pal R, Hameed S, Kumar P, Singh S, Fatima Z. Underst anding lipidomic basis of iron limitation induced chemosensitization of drug-resistant Mycobacterium tuberculosis.3 Biotech. 2019 Apr;9(4):122. doi: 10.1007/s13205-019-1645-4.
323. Kant K, Tomar AK, Singh S, Yadav S. Ageing associated proteomic variations in seminal plasma of Indian men. Journal of Proteins and Proteomics. 2019 Jun 1; 10(2):83-9.DOI: 10.1007/s42485-019-00013-x.
324. Kant K, Tomar AK, Sharma P, Kundu B, Singh S, Yadav S. Human Epididymis Protein 4 Quantification and Interaction Network Analysis in Seminal Plasma. Protein Pept Lett. 2019 Jul 4; 26(6):458-465. doi: 10.2174/0929866526666190327124919. PubMed PMID: 30919767.
325. Shankar P, Mishra J, Bharti V, Parashar D, Singh S. Multiplex PCR assay for simultaneous detection and differentiation of Entamoeba histolytica, Giardia lamblia, and Salmonella spp. in the municipality-supplied drinking water. J Lab Physicians. 2019 Jul-Sep;11(3):275-280. doi: 10.4103/JLP.JLP_66_18. PubMed PMID: 31579243; PubMed Central PMCID: PMC6771313.
326. Chauhan V, Singh S, Galwankar S, Aggarwal P, Bhoi S, Di Somma S, Peacock WF, Paladino L. Establishing national centre for point-of-care technology for ‘Swasth Bharat, Samridh Bharat’. J Lab Physicians. 2019 Jul-Sep;11(3):177-179. doi: 10.4103/JLP.JLP_139_19. PubMed PMID: 31579259; PubMed Central PMCID: PMC6771327.
327. Rajni E, Ghiya BC, Singh S, Shankar P, Swami T, Jadon DS, Negi SR, Malik M, Khatri PK. Cutaneous leishmaniasis in Bikaner, India: Clinicoepidemiological profile; parasite identification using conventional, molecular methods and CL Detect™ rapid test, a new Food and Drug Administration-approved test. Trop Parasitol. 2019 Jul-Dec;9(2):115-123. doi: 10.4103/tp.TP_1_19. Epub 2019 Sep 18. PubMed PMID: 31579666; PubMed Central PMCID: PMC6767788.
328. Verma T, Podder S, Mehta M, Singh S, Singh A, Umapathy S, N andi D. Raman spectroscopy reveals distinct differences between two closely related bacterial strains, Mycobacterium indicus pranii and Mycobacterium intracellular. Anal Bioanal Chem. 2019 Dec; 411(30):7997-8009. doi: 10.1007/s00216-019-02197-z. Epub 2019 Nov 16. PubMed PMID: 31732785.
329. Singh S. Face to face: Leishmaniasis and its changing patterns. Trop Parasitol. 2019 Jul-Dec; 9(2): 133–137. doi: 10.4103/tp.TP_48_19.
330. Jain P, Ojha SK, Kumar V, Bakhshi S, Singh S, Yadav S. Differential seminal plasma proteome signatures of acute lymphoblastic leukemia survivors. Reprod Biol. 2019 Dec; 19(4):322-328. doi: 10.1016/j.repbio.2019.11.002. Epub 2019 Nov 8. PubMed PMID: 31711845.
331. Batra P, Batra M, Singh S. Epidemiology of TORCH Infections and Underst anding the Serology in Their Diagnosis. J. Fetal Med. 7, 25–29 (2020). https://doi.org/10.1007/s40556-019-00232-8.
332. Sharma V, Makhdoomi M, Singh L, Kumar P, Khan N, Singh S, Verma HN, Luthra K, Sarkar S, Kumar D. Trehalose limits opportunistic mycobacterial survival during HIV co-infection by reversing HIV-mediated autophagy block. Autophagy. 2020 Feb 20:1-20. doi: 10.1080/15548627.2020.1725374. [Epub ahead of print] PubMed PMID: 32079455.
333. Barr DA, Lewis JM, Feasey N, Schutz C, Kerkhoff AD, Jacob ST, Andrews B, Kelly P, Lakhi S, Muchemwa L, Bacha HA, Hadad DJ, Bedell R, van Lettow M, Zachariah R, Crump JA, All and D, Corbett EL, Gopinath K, Singh S, Griesel R, Maartens G, Mendelson M, Ward AM, Parry CM, Talbot EA, Munseri P, Dorman SE, Martinson N,Shah M, Cain K, Heilig CM, Varma JK, Gottberg AV, Sacks L, Wilson D, Squire SB, Lalloo DG, Davies G, Meintjes G. Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual patient data. Lancet Infect Dis. 2020 Mar 13. pii: S1473-3099(19)30695-4. doi: 10.1016/S1473-3099(19)30695-4. [Epub ahead of print] PubMed PMID: 32178764.
334. Martinez L, Cords O, Horsburgh CR, Andrews JR; Paediatric TB Contact Studies Consortium. The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis. Lancet. 2020 Mar 21; 395(10228):973-984. doi: 10.1016/S0140-6736(20)30166-5. PubMed PMID: 32199484.
335. Rufai SB, Umay K, Singh PK, Singh S. Performance of Genotype MTBDRsl V2.0 over the Genotype MTBDRsl V1 for detection of second line drug resistance: An Indian perspective. PLoS One. 2020 Mar 4;15(3):e0229419. doi: 10.1371/journal.pone.0229419. eCollection 2020. PubMed PMID: 32130233; PubMed Central PMCID: PMC7055869.
336. Singh S. Rapid Antibody-based test for the diagnosis of Covid-19:A bigger epidemic of unscientific practice. J Lab Physicians. 2020 March. DOI:http://doi.org/10.1055/s-0040-1712711.
337. Singh PK, Kulsum U, Rufai SB, Mudliar SR, Singh S. Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development. J Lab Physicians. 2020 Aug;12(2):154-160. doi: 10.1055/s-0040-1715790. Epub 2020 Sep 1. PMID: 32884216; PubMed Central PMCID: PMC7462717.
338. Srivastava S, Verma S, Kamthania M, Agarwal D, Saxena AK, Kolbe M, Singh S, Kotnis A, Rathi B, Nayar SA, Shin HJ, Vashisht K, P andey KC. Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch vaccines, designed by reverse epitomics approach, show potential to cover large ethnically distributed human population worldwide. J Biomol Struct Dyn. 2020 Nov 6;:1-20. doi: 10.1080/07391102.2020.1838329. PMID: 33155524; PubMed Central PMCID: PMC7651196.
339. Singh AK, NemaRK, Joshi A, Shankar P, Nema S, Raghuwanshi A, Patankar C, Mathew BJ, Shrivas A, P andey R, Tripathi R, Biswas D, Singh S. Evaluation of pooled sample analysis strategy in expediting case detection in areas with emerging outbreaks of COVID-19: A pilot study. PLoS One. 2020;15(9):e0239492. doi: 10.1371/journal.pone.0239492. PMID: 32960929; PubMed Central PMCID: PMC7508355.
340. Mangalgi S, Madan K, Das CJ, Singh G, Sati H, Kanwar Yadav R, Xess I, Singh S, Bhowmik D, Agarwal SK, Bagchi S. Pulmonary infections after renal transplantation: a prospective study from a tropical country. Transpl Int. 2021 Mar;34(3):525-534. doi: 10.1111/tri.13817. Epub 2021 Feb 26. PubMed PMID: 33423313.
341. Dhingra B, Singh S. Pneumococcal vaccination in persons living with HIV: Pneumococcal conjugate, polysaccharide or both?. EClinicalMedicine. 2020 Dec;29-30:100593. doi: 10.1016/j.eclinm.2020.100593. eCollection 2020 Dec. PubMed PMID: 33305195; PubMed Central PMCID: PMC7708955.

*indicates corresponding author

PUBLICATION FOR GENERAL PUBLIC/ MASS COMMUNICATION
i) Public Awareness talks and discussion on COVID-19 at Door Darshan (live TV) Bhopal, in 2020
ii) Regularly invited byDoor Darshan (live TV) Bhopal, or health topics since August 2018 till date
iii) Participated at various Radio awareness programmes of Akashwani, Bhopal ( All India Radio) and private FM (Radio Mirchi) on topic like PM-JAY scheme of Prime minister, Threat of antibiotic resistance and COVID-19, since 2018 to date
iv) Radio Talk (Live) on Tuberculosis. All India Radio FM Gold. New Delhi, 23rd March 2015,
v) TV interview on Tuberculosis. Rajya Sabha TV. New Delhi, Telecast on 24th March 2015,
vi) Radio Talks (Live) on Tuberculosis. All India Radio FM Gold. New Delhi, 24th March 2014,
vii) TV interview on Tuberculosis. News Nations TV. New Delhi, Telecast on 24th March 2014,
viii) Radio Talks (Live) on Tuberculosis. All India Radio FM Gold. New Delhi, 23rd March 2013.
ix) Dozens of articles and Interviews on COVID-19: its prevention, Diagnosis etc published in various English ad Hindi Newspapers 2020
x) Articles and interviews on Drug Resistance in Tuberculosis published in top ranking daily news papers such as The Independent, The Times of India, The Hindu, Hindustan Times, Gulf News etc. 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017.
xi) Several articles and interviews on Banning the Serology for TB diagnosis published in top ranking daily news papers such as The TIMES, The Times of India, The Hindu, Indian Express, Hindustan Times, Gulf News etc. 2010-11.
xii) Written several articles on Toxoplasmosis and its zoonotic importance in Daily news papers and magazines both in Hindi and English including PTI and Univarta.
xiii) An Interview of International importance on “Risks of hospital acquired infections AIDS & HBV infection” published in New Scientists (Engl and) August 3, 1991, p10.
xiv) Written several educational articles for Hindi and English news papers on Kala-azar for general public.
xv) Presently scientist on panel for “Univarta”: articles of public interest published on Toxoplasmosis, Genetic & Congenital infectious disease and on PCR based diagnoses.
xvi) Publications of mass awareness about water contamination in Delhi, through PTI, Times of India, HT, Tribune, etc.
xvii) Published several pamphlets and h andbooks/h andouts in Hindi language for public awareness various diseases and their diagnosis.
xviii) Participated in a “Documentary film on Universal Precautions” directed by Dr. Ashok Rattan and Produced by AIIMS, New Delhi, 1993.
xix) Participated as subject expert in a “Documentary film on AIDS: its social impact” produced by Mass Communication Centre, Jamia Millia University, Delhi, 1992.
xx) Mass awareness articles in Nav Bharat Times, Hindustan, Tribune (Hindi) and TOI, Hindustan (English) on Toxoplasmosis, 1998, 1999, 2000.

Important Links

Contact Me

Former Director & CEO
All India Institute of Medical Sciences, Bhopal-462020
Madhya Pradesh
Email: sarman.singh@gmail.com